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Abstract 
Clostridium difficile is the causative agent of antibiotic-associated diarrhea and 
pseudomembranous colitis and the most important reason of nosocomial infections. The 
major virulence factors are toxins A and B, which are encoded by the pathogenicity locus 
(PaLoc). The small open reading frame tcdE within the PaLoc is located between the genes 
for the pathogenic toxins A (TcdA) and B (TcdB). The role of the deduced 19 kDa protein TcdE 
with respect to C. difficile virulence is not yet known. Sequence and structure homologies to 
bacteriophage encoded holins led to the hypothesisof a TcdE-induced release of the 
pathogenic toxins from C. difficile into the extracellular environment as consequence of 
bacterial lysis. Further assumptions focused on a tcdE-mediated regulation of the toxin 
genes, however, both hypotheses lack evidences so far. 
The present study investigates a potential impact of TcdE on Escherichia coli K12 as 
representatives of the commensals residing in the C. difficile habitat. TcdE function was 
further analyzed with respect to C. difficile growth, sporogenesis and toxin release by 
generating a TcdE-deficient C. difficile mutant strain. 
Expression of TcdE in E. coli correlated with bacterial cell death monitored by a decrease in 
cell count accompanied by release of ATP. Structure-function analysis using deletion mutants 
of TcdE revealed an essential role of the three transmembrane domains with regard to 
bacteriolysis and a modulatory impact of the N- and C-termini. TcdE exhibits an alternative 
ribosome binding site combined with a dual start motif leading to expression of the 19 kDa 
full length TcdE and an N-terminal shortened 16 kDa product with a ratio 1 : 10. The 
truncated TcdE was shown to be crucial for bacteriolysis and the full length form to inhibit 
lysis function. 
Since full length as well as truncated TcdE did not damage isolated mitochondria, affect cell 
and nuclei morphology or induce apoptotic cascades after transfection in epithelial cells, 
TcdE is unlikely to be a pathogenicity factor acting on target cells of C. difficile. 
Analyses of the TcdE-deficient C. difficile mutant revealed that TcdE does not regulate 
C. difficile growth or sporogenesis. Furthermore, TcdE knockout neither alters kinetic of toxin 
release nor the absolute TcdA and TcdB protein levels, refuting the often discussed 
hypothesis of a TcdE-mediated release of the pathogenic toxins as a result of bacterial lysis. 
The present study disproves TcdE to function as virulence factor or the controversially 
discussed cause for toxin release. However, TcdE was shown to induce cell death of Gram 
negative bacteria by an N-terminal truncated form which is not produced in C. difficile. Data 
indicate that TcdE might have antimicrobial impact on intestinal commensals or prevent the 
virulence mediating pathogenicity locus of C. difficile from being utilized by other bacterial 
species since expression of short TcdE would cause cell death.   
Key words: Clostridium difficile, TcdE, bacterial lysis 
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Zusammenfassung  
Clostridium difficile ist der Auslöser der Antibiotika- assoziierten Diarrhöe und 
Pseudomembranösen Colitis und stellt den Hauptversursacher nosokomialer Infektionen 
dar. Der kleine offene Leserahmen tcdE innerhalb des C. difficile Pathogenitätslocus‘ ist 
zwischen den Genen der pathogenen Toxine A (TcdA) und B (TcdB) lokalisiert. Bisher ist 
unklar, welche Rolle das putative 19 kDa- Protein TcdE bei der Virulenz von C. difficile spielt. 
Sequenz- und Strukturhomologien zwischen TcdE und Bakteriophagen-codierten Holinen 
führten zur Hypothese einer Freisetzung von TcdA/B infolge einer TcdE-verursachten 
Bakteriolyse.  Alternativ wurde eine tcdE-vermittelte Regulation der Toxin-Gene vermutet. 
Für beide Hypothesen wurden bislang keine eindeutigen Beweise erbracht. 
Die vorliegende Arbeit untersucht die Wirkung von C. difficile TcdE auf Escherichia coli K12 
als Vertreter intestinaler Kommensalen. Um zusätzlich einen möglichen Einfluss von TcdE auf 
das Clostridien-Wachstum, die Sporulation oder dessen Toxin-Freisetzung zu analysieren, 
wurde eine TcdE-defiziente C. difficile-Mutante generiert.  
Die Expression von TcdE in E. coli korrelierte mit einer Bakteriolyse, die durch Reduktion der 
Bakterienzahl und gleichzeitiger ATP-Freisetzung erfasst wurde. Struktur- Wirkungs-Analysen 
mit TcdE- Deletionsmutanten konnten eine essentielle Rolle der drei Transmembran-
domänen und eine Modulatorfunktion des N- und C- Terminus‘ deutlich machen. Eine 
alternative Ribosomen-Bindestelle kombiniert mit einem dualen Startmotiv innerhalb der 
tcdE- mRNA führten zur Expression des Holo-TcdEs (19 kDa) und einer N- terminal 
verkürzten Form (16 kDa). Die Studie belegt, dass die Bakteriolyse durch das verkürzte TcdE 
vermittelt wird, wohingegen das Holo-TcdE als dessen Antagonist, dem Lyse-Inhibitor, agiert. 
Eine potentielle Funktion von TcdE als weiterer Pathogenitätsfaktor wurde durch 
Transfektionsexperimente untersucht. Da weder das Holo-TcdE noch die verkürzte Form die 
Zell- oder Zellkern-Morphologie beeinflussen, zu einer Schädigung isolierter Mitochondrien 
führen oder Apoptose induzieren, wird eine pathogene Wirkung von TcdE ausgeschlossen. 
Zur weiteren Untersuchung der Funktion von TcdE wurde über die ClosTron-Technik das 
tcdE-Gen in Clostridien funktionell inaktiviert. Mithilfe dieser TcdE-defizienten C. difficile-
Mutante konnte gezeigt werden, dass TcdE weder in die Regulation des C. difficile-
Wachstums oder der Sporulation involviert ist, noch die oft diskutierte Freisetzung der 
Toxine A und B als Folge von Bakteriolyse bewirkt. 
Die Ergebnisse der vorliegenden Arbeit schließen eine Funktion von TcdE als Virulenzfaktor 
aus und widerlegen die kontrovers diskutierte Hypothese einer TcdE- vermittelten 
Freisetzung der Pathogenitätsfaktoren. Allerdings induziert TcdE über eine N- terminal 
verkürzte Form die Lyse Gram-negativer Bakterien, was auf eine potentielle antimikrobielle 
Wirkung gegenüber intestinalen Kommensalen hindeutet. Alternativ könnte TcdE vor einer 
„Fremdnutzung“ des PaLoc schützen, da dessen Integration in die DNA Gram-negativer 
Bakterien nach Expression des kurzen TcdE die Lyse der Bakterien zur Folge hätte.   
Schlagwörter: Clostridium difficile, TcdE, Bakteriolyse 
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1. Introduction 
 
1.1 Clostridium difficile  
 
Clostridium difficile is a Gram positive, facultative anaerobic rod of the Clostridiaceae family. 
The spore-forming bacterium is ubiquitous distributed and resides in the human intestine in 
2-5% of the population. C. difficile was first described in 1935 when it was found in the 
intestine of healthy new born infants (Hall and O’Toole, 1935). With the introduction of 
broad-spectrum antibiotics, antibiotic-associated diseases occurred. Few years later, 
C. difficile was identified as the responsible pathogen causing antibiotic-associated diarrhea 
and the more severe form, the pseudomambranous colitis (Larrson and Proce, 1977; Bartlett 
et al., 1978). 
In the last centuries, incidence of C. difficile associated diseases (CDAD) increased resulting 
from enhanced application of broad-spectrum antibiotics, such as aminopenicillins, 
cephalosporins and clindamycin. These antibiotics cause disruption of the normal intestinal 
flora facilitating colonization and overgrowth of C. difficile (Just et al., 2000). C. difficile is 
spread fecal-orally through resistant endospores. Sporulation is of ecological advantage to 
the organism as it enables to survive under adverse conditions. Thus, sporulation normally 
occurs under condition of nutrients depletion. A variety of factors such as pH, 
media composition and ionic strength are known to affect sporulation. 
 Upon spore ingestion, germination to vegetative cells occurs within the colon followed by 
proliferation and release of the major pathogenicity factors, toxin A (TcdA) and B (TcdB) 
(Lyerly and Wilkins, 1995). The toxins are single chain proteins belonging to the family of 
large clostridial cytotoxins. They share 63 % sequence homology and are responsible for 
disease manifestations to the greatest extend (Von Eichel-Streiber et al., 1992). 
 Historically, TcdA (308 kDa) was termed enterotoxin because of inducing typical symptoms 
of colitis in animal models (Lyerly et al., 1985; Triadafilopoulos et al., 1987). In contrast, TcdB 
(270 kDa) did not exhibit enterotoxic properties towards animals, but possess a 100- to 1000 
higher cytotoxic potency in cell culture than TcdA and thus, was designated as cytotoxin 
(Lyerly et al., 1982). However, recently it was shown that TcdB is essential for virulence of 
C. difficile since TcdA- deficient C. difficile mutants still producing TcdB retained a wildtype 
virulence phenotype whereas the disruption of exclusively tcdB resulted in a significant 
attenuation of virulence in hamsters (Lyras et al., 2009). In vitro, both toxins cause 
reorganization of the actin cytoskeleton accompanied by shrinking and rounding of the 
cultured cells (cytopathic effect). This effect is based on a glucosyltransferase activity of TcdA 
and TcdB towards their substrate proteins, the Rho family GTPases (Just et al., 1995). Both 
toxins monoglucosylate a Threonin residue within the effector domain of Rho proteins (RhoA 
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at Thr-37; Rac-1, Cdc42 and Ras at the homolog residue Thr-35) resulting in inhibition of 
effector coupling and subsequent blocking of signal transduction pathways. Since Rho 
GTPases regulate dynamics of the actin cytoskeleton (Hall, 1998) toxin-catalyzed 
glucosylation also affects cell division, migration, morphogenesis (Jaffe and Hall, 2005) and 
epithelial barrier functions (Riegler et al., 1997; Lawrence et al., 1997; Nusrat et al., 2001; 
Schoentaube et al., 2009). Furthermore, Rho-GTPases induce apoptosis in cells, designated 
as cytotoxic effect (Nottrott et al., 2007; Gerhard et al., 2008). 
Clinical disease associated with C. difficile has varying clinical features ranging from self-
limited watery diarrhea with fever, abdominal pain and leycocytosis, to life-threatening 
pseudomembranous colitis and toxic megacolon (Rubin et al., 1995). The different types of 
clinical characteristics likely present the result of cellular and molecular interactions 
between the C. difficile toxins and host intestinal defense mechanisms. The toxins trigger the 
attraction and adhesion of neutrophils resulting in inflammation of the mucosal lining and 
cellular necrosis, as well as increased capillary permeability due to an opening of the tight 
junctions, leading to diarrhea and colitis (Poxton et al., 2001; Durai, 2007). In addition, TcdA 
induces the production of TNF-α and pro-inflammatory interleukins which further facilitate 
the associated inflammatory response and pseudomembrane formation (Poxton et al., 
2001). The pseudomembranes appear as yellow-white plaques composed of neutrophils, 
fibrin, mucin and cellular debris. 
 
 
 
 
 
Fig. 1.1: Pseudomembranous colitis. Colonoscopial view of the typical yellow-white pseudomembranous fibrin plaques. 
Source: www.endoline.de/html/darmerkrankungen.html, 10.05.2009 
 
 
Diagnosis of infection with pathogenic C. difficile typically occurs by detection of the toxins 
TcdA and TcdB in stool samples by means of enzyme immunoassays (EIA) or the 
conventional cell cytotoxicity assay (Bartlett and Gerding, 2008). 
C. difficile associated disease (CDAD) is usually treated orally with metronidazole or 
vancomycin following cessation of the inciting antibiotics. Metronidazole and vancomycin 
are comparable regarding efficacy and relapse rates (Wenisch et al., 1996; Zar et al., 2007). 
Given the higher cost of oral vancomycin therapy and concern about selection for 
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vancomycin-resistant enterococci, metronidazole is preferred as the initial agent of choice 
(Surowiec et al., 2006; Durai, 2007; Owens, 2007). However, reports of metronidazole 
inferiority in treating severe disease have recently emerged (Musher et al., 2005; Zar et al., 
2007; Al-Nassir et al., 2008). Adjunctive and alternative therapeutic approaches are being 
investigated. Antimicrobial agents, e.g. Ramoplanin and Rifaximin, human monoclonal 
antibodies as toxin neutralizing agent and vaccines against C. difficile are being evaluated 
(Aslam et al., 2005; Hedge et al., 2008). Furthermore, use of intravenous gamma globulin 
administration (Leung et al., 1991; Salcedo et al., 1997) and probiotics (McFarland, 2006) can 
be considered. 
C. difficile infection is acquired fecal-orally through endospores resistant towards heat (< 
120°C), alcohol based disinfectants and broad spectrum antibiotics. It is considered as main 
anaerobic pathogen causative for nosocomial infections, however, incidence of community-
acquired C. difficile infections has increased within the last years.  
The risk of enhanced C. difficile colonization correlates with advanced age, severe underlying 
disease of the host and a compromised immune system (Frost et al., 1998). 
 
 
 
1.2 Clostridium difficile strains and toxinotypes 
 
Several typing methods are developed to differentiate Clostridium difficile strains. Initial 
molecular methods involved plasmid analysis and whole-genome restriction enzyme analysis 
(REA). REA typing is based on Hind III restriction of genomic DNA leading to a strain specific 
fragment pattern. However, since this process is very time-consuming and the REA pattern 
difficult to interpret, it is not routinely used (Rafferty et al., 1998). Rather, PCR ribotyping is 
used to detect specific sequence polymorphisms enabling the differentiation of strains of the 
same species. This method relies on amplification of the 16S-23S rRNA intergenic spacer 
region resulting in different PCR ribotype patterns reflecting strain-dependent variations in 
the possession of different rRNA alleles (Cartwright et al., 1995). 
Clostridium difficile strains are classified into toxinotypes (I-XXIV) which are defined by 
changes in the pathogenicity locus (Rupnik et al., 1998). Toxinotypes are differentiated by a 
method, designated Toxinotyping, which is based on RFLP-PCR (Restriction Fragment Length 
Polymorphism). Therefore, parts of the toxin genes are ampliﬁed and the resulting PCR 
fragments are scanned for length polymorphisms and digested with different restriction 
enzymes to monitor restriction fragment length polymorphisms (RFLPs). According to the 
observed patterns a strain is grouped within a given toxinotype (Rupnik et al., 1998; Rupnik 
et al., 2008). Toxinotype 0 strains contain a pathogenicity locus identical to the reference 
strain VPI10463 whereas variant C. difficile strains are defined by changes in the 
pathogenicity locus resulting in altered toxin production. Thus, C. difficile is a very 
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heterogeneous species with strains possessing different toxin production types according to 
the combination of the three toxins: TcdA, TcdB and the binary toxin CDT. 
Among the reference strain C. difficile VPI10463 the virulent and drug-resistant strain 630 
and different variant strains were used in this study (Tab. 1.1). Clostridium difficile strain 196 
(PCR ribotype 027) has been identified in recent nosocomial outbreaks and infections with 
increasing incidence and severe disease. It presents higher pathogenicity presumably 
because of increased toxin production and a characteristic antibiotic resistance profile 
(Pepin et al., 2004; McDonald et al., 2005; Warny et al., 2005). Its high toxin yield may 
partially be caused by a frameshift mutation in tcdC, encoding a negative regulator of TcdA 
and TcdB expression (Mani and Dupuy, 2001; Matamouros et al., 2007; Wolff et al., 2009).   
 
 
C. difficile strain Toxin producing type Toxinotype 
 
VPI10463 
 
630 
 
1470** 
 
196 
 
 
A+ B+ CDT- 
 
A+ B+ CDT-* 
 
A- B+ CDT-  
 
A+ B+ CDT+ 
 
                      0 
 
                      0 
 
    VIII 
 
III 
 
 
Tab. 1.1: List of Clostridium difficile strains and the respective toxin producing- and toxinotypes. The toxin producing type 
of the C. difficile strains expresses exhibition of the toxins A (TcdA), B (TcdB) and CDT (binary toxin). Additional the 
toxinotype is given which classifies C. difficile strains and is defined by changes in the pathogenicity locus. (*The genes 
encoding CDT are present as pseudogenes exhibiting stop codons and frame-shift mutations; ** Source: Pituch 
et al., 2007) 
 
 
 
1.3 Clostridium difficile: Genome and pathogenicity locus 
 
Sequencing of the genome of C. difficile strain 630 has recently been completed at the 
Sanger Institute UK (http://www.sanger.ac.uk/Projects/C_difficile/, 10.05.09). It consists of a 
circular chromosome containing 4,290,252 bp and a plasmid with 7881 bp. Only 15 % of 
C. difficile coding sequences (CDSs) are shared with other sequenced clostridia species (e.g. 
C. botulinum, C. tetani and C. perfringens) encoding mainly essential functions. Interestingly, 
50 % of the CDSs are unique to C. difficile basically encoding accessory proteins and mobile 
elements (Sebaihia et al., 2006). C. difficile 630 revealed a large proportion (11%) of mobile 
genetic elements, mainly in the form of conjugative transposons (Sebaihia et al., 2006). 
Pathogenic C. difficile strains possess a 19.6 kb chromosomal genetic locus, designated as 
pathogenicity locus (PaLoc).  
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Fig. 1.2: Pathogenicity locus (PaLoc) of Clostridium difficile. The genes for the toxins TcdA and TcdB (tcdA and tcdB) are 
part of a 19.6 kb genetic locus including additional three open reading frames designated tcdC, tcdD and tcdE. The direction 
of the arrows reflects orientation of transcription.    
 
 
The PaLoc harbors the genes encoding the pathogenicity factors TcdA and TcdB and is a 
prerequisite for virulence. In nontoxigenic strains the pathogenicity locus is replaced by a 
115 bp fragment (Hammond and Johnson, 1995; Braun et al., 1996), suggesting that the 
PaLoc represents a mobile genetic element. However, investigations did not support this 
hypothesis since tRNA genes are missing which often account for integration sites of genetic 
elements. In addition, no short inverted terminal repeats were identified usually involved in 
the transposition process (Braun et al., 1996).   
Among the genes for the toxins TcdA and TcdB, the pathogenicity locus harbors another 
three genes of partially unknown function with regard to C. difficile virulence. The tcdD gene, 
located upstream of tcdB, was demonstrated to promote up-regulation of TcdA- and TcdB 
synthesis by encoding an alternative sigma factor crucially involved in transcription initiation  
(Missiakas and Raina, 1998; Mani and Dupuy, 2001; Mani et al., 2002; Karlsson et al., 2003). 
Conversely, a negative regulatory function has been proposed for tcdC which is positioned 
downstream of tcdA and is transcribed in opposite direction (Hundsberger et al., 1997; 
Hammond et al., 1997). TcdE is an open reading frame located between the genes for the 
toxins TcdA and TcdB and further described in the following section.  
A third toxin, not related to TcdA and TcdB, was identified in certain C. difficile strains, 
named binary toxin CDT. CDT is member of the binary toxins produced by Clostridium 
perfringens (type E) and Clostridium botulinum (types C and D) (Rupnik et al., 2003b; Rupnik, 
2008). Binary toxins are ADP-ribosyltransferases directly modifying actin molecules (Perelle 
et al., 1997). Its role in pathogenesis is still controversially discussed (Geric et al., 2006). 
 
 
 
1.4 Clostridium difficile TcdE 
 
The small open reading frame tcdE is part of the pathogenicity locus of Clostridium difficile 
and consists of about 500 bp. It is located between the genes encoding the pathogenicity 
factors TcdA and TcdB, more precisely 122 bp downstream of the tcdB stop codon and 727 
bp upstream of the tcdA start codon (Hammond and Johnson, 1995). TcdE encodes the 
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putative protein TcdE consisting of 166 amino acids with a deduced molecular weight of 19 
kDa (Tan et al., 2001). TcdE was predicted to be highly hydrophobic exhibiting three 
transmembrane domains which are connected via hydrophilic regions. Transmembrane 
prediction was performed using the Dense Alignment Surface method (Stockholm University, 
accessible on Expasy Tools) which discriminates between soluble and membrane proteins by 
searching for α-helical regions within the submitted protein sequence. 
 
 
 
Fig. 1.3: Hydrophobicity plot of Clostridium difficile TcdE. Prediction of transmembrane regions in Clostridium difficile TcdE 
using the Dense Alignment Surface method (Stockholm University). TcdE is predicted to exhibit three transmembrane 
domains connected by hydrophilic stretches. The area above the horizontal lines indicate the hydrophobic regions of the 
TcdE protein (solid line: strict cut off, dashed line: loose cut off). The x-axis represents the amino acid residues.   
 
 
Amino acid sequence analysis further revealed a short hydrophilic stretch at the N-terminus 
and charge-rich residues at the C-terminus of the protein (Tan et al., 2001).  
Although TcdE sequence was analyzed in 1990 (Dove et al., 1990) the function of the 
hydrophobic protein is yet to be defined. Structural similarities to holin proteins and the 
observation that TcdE expression in Escherichia coli resulted in a loss of culture turbidity 
raised the assumption of a holin-like function of TcdE (Wang et al., 2000; Tan et al., 2001). 
Transcription analysis revealed a polycistronic transcription of the PaLoc genes tcdA,B,D,E in 
addition to the monocistronic transcription of the genes tcdA and tcdB indicating that TcdC-E 
are involved in C. difficile pathogenicity as well. Among transcriptional regulation of TcdE via 
the tcdD- and tcdB promoters, tcdE was supposed to have an own promoter since promoter 
elements, like the -35 and -10 boxes match well with those of the deduced tcdA/B 
promoters. Additionally, RT-PCR approaches revealed that mRNAs of tcdA, tcdB and tcdE are 
produced during the late exponential growth phase of C. difficile indicating a simultaneous 
expression of TcdE and TcdA/B after the stationary phase of growth (Hundsberger et al., 
1997).     
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1.5 Holins 
 
Holins are small bacteriophage-encoded membrane proteins controlling the length of an 
infection cycle of tailed phages. During phage assembly, holin molecules accumulate in the 
cytoplasmic membrane without detectable effect on the host (Wang et al., 2000; Gründling 
et al., 2001; Park et al., 2007). At a precisely scheduled time, which is programmed into their 
primary structure, holins trigger disruption of the cytoplasmic membrane by oligomerization 
and forming lethal holes within the membranes. Subsequently, a second class of 
bacteriophage-encoded proteins, the muralytic endolysins, pass these pores and cleave the 
peptidoglycan polymer causing cell lysis (Gründling et al., 2001; Park et al., 2006).  
The group of holins is extremely diverse but on the basis of primary structure and membrane 
topology two classes are distinguished. Class I holins, e.g. lambda holin (Sλ), exhibit usually 
more than 90 amino acid residues and possess two or rather three transmembrane domains 
(TMD). Analysis of the charge distribution assumed a periplasmic N-terminus and a cytosolic 
C-terminus. Class II holins, the prototype is the S protein from lambdoid phage 21 (S21), are 
75 residues or less in length and exhibit two putative TMDs with both termini located in the 
cytosol (Bonovich and Young, 1991; Young, 1992; Young and Bläsi, 1995) (Fig. 1.4).     
 
 
Fig. 1.4: Putative transmembrane topologies of the holins S
λ
 and S
21
 (Young et al., 2000). 
 
 
Interestingly, genetic analysis of λ-phage revealed a second start codon (Met) separated 
from the first by only one lysine residue. Both Met codons are utilized for translation 
initiation resulting in proteins of different length and function, designated S107 and S105 
with respect to their length in amino acid residues (Bläsi et al., 1989; Bläsi et al., 1990; Wang 
et al., 2000). S105 is the active holin of λ-phage, whereas the two amino acids longer S107 
acts as its inhibitor, named the antiholin. The inhibitory function was proposed to be based 
on the extra positively charged Lys-residue preventing the first transmembrane domain from 
integrating into the membrane (Graschopf and Bläsi, 1999). The S107 protein exhibits only 
two TMDs and dimerizes with and thereby inactivates the holin S105. The proteins S105 and 
S107 are usually expressed at a ratio of 2:1 (Chang et al., 1995; Bläsi et al., 1996) regulated 
by an RNA-stem-loop structure, called sdi (structure-directed initiation), that determines 
lysis timing.  
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Furthermore, previous studies indicated that the lysis causing pore formation assumes 
oligomerization of S105 to two-dimensional protein aggregates, designated as ‘death rafts’ 
(Gründling et al., 2000a; Wang et al., 2003). Fig.1.5 illustrates the proposed process of pore 
formation. S105 molecules (each circle) accumulate and oligomerize within the cytoplasmic 
membrane (1. and 2.) developing the ‘death raft’ (3.). Interaction of the molecules derives 
via their transmembrane domains. Following opening of an aqueous channel (4.) local 
depolarization of the cytoplasmic membrane occurs, which triggers conformational changes 
in the holins and further expansion of the lesion. 
 
 
 
 
Fig. 1.5: The ‘death raft’ model for holin lesion formation. Following accumulation and oligomerization of the S105 
molecules (1+2, each circle represents a single molecule) formation of the ‘death raft’ occurs (3). Opening of an aqueous 
channel (4) triggers conformational changes in the holins resulting in subsequent dispersion of the lesion within the 
cytoplasmic membrane (Krupovic et al., 2008).      
 
 
Further investigations revealed that detergent-solubilized λ-holin formed large ring-shaped 
structures which stacked onto each other to establish larger tubular assemblies. 
Examinations of the S105 assemblies by means of cryo-Electron microscopy exposed a three-
dimensional structure of a λ-holin ring-dimer (Fig. 1.6, upper panel) with an outer diameter 
of 23 nm and an inner diameter of 9 nm. The height of each ring monomer (4 nm) closely 
matched the thickness of a lipid bilayer (Fig. 1.6, lower panel) supporting the ‘death raft’ 
model (Savva et al., 2008).    
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Fig. 1.6: Three-dimensional reconstruction of a λ-holin ring-dimer on the basis of Electron microscopy. Detergent-
solubilized λ-holin formed large, well-dispersed ring-shape structures stacking onto each other to form larger tubular 
assemblies (upper panel). Since the height of each ring monomer closely matched the thickness of a lipid bilayer (4 nm), a 
model for integration of a single-ring within the lipid bilayer was proposed (lower panel) (Savva et al., 2008). 
 
 
1.6 Homologies between Clostridium difficile TcdE and 
holins 
 
Clostridium difficile TcdE is a highly hydrophobic 19 kDa protein of unknown function. 
Interestingly, amino acid sequence analysis revealed more than 20 % identity and 50 % 
similarity of TcdE and holins from different bacteriophage species (e.g. 23 % identity and 
54 % similarity to holin 87 of Streptococcus thermophilus bacteriophage Sfi19 and 25 % 
identity and 52 % similarity to Bacillus subtilis bacteriophage B103 holin). The highest 
homology between TcdE and holins was detected within the C-terminus of TcdE flanked by 
amino acids 121 and 166 (Tan et al., 2001). 
Among sequence homologies, Clostridium difficile TcdE and bacteriophage-encoded holins 
share structural similarities based on resemblance in the distribution of hydrophilic and 
hydrophobic amino acids. Holins are small membrane-spanning proteins possessing a 
hydrophilic N-terminus and a highly charged C-terminus (Young and Bläsi, 1995). Consistent 
with this, on the basis of hydrophobicity analysis TcdE was predicted to exhibit three 
transmembrane domains. Furthermore, amino acid sequence analysis of TcdE also revealed 
a hydrophilic stretch at the N-terminus and a charge-rich C-terminus (Tan et al., 2001).   
Interestingly, additional to striking resemblance in sequence and structure, TcdE was shown 
to exhibit holin-like functional properties since TcdE expression in Escherichia coli resulted in 
a sudden halt of bacterial growth and gradual loss of culture turbidity (Tan et al., 2001).  
An important characteristic of holins is the dual start motif resulting in proteins of different 
length and function, a holin and its inhibitor. Analysis of TcdE nucleic acid sequence exposed 
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two additional ATG start codons contributing to amino acids 25 and 27. Furthermore, an 
alternative ribosome binding site was found upstream of both the first (GGTGG) and third 
(GGAGG) start codons of tcdE (Dove et al., 1990) indicating an existence of a dual start motif 
in tcdE mRNA as well. The deduced molecular weights of the putative proteins initiating 
from the first and third start codons are 19 kDa and 16 kDa, respectively.  
Since tcdE was shown to be transcribed polycistronically with the tcdA and tcdB genes, the 
putative TcdE protein was attributed to play a crucial role in the pathogenicity of C. difficile 
(Von Eichel-Streiber et al., 1987; Hundsberger et al., 1997). On the one hand, TcdE was 
postulated to have regulatory function with respect to the toxin genes tcdA and tcdB (Dove 
et al., 1990). Otherwise, Von Eichel-Streiber and Sauerborn hypothesized that TcdE 
facilitates the release of the pathogenic toxins, due to its holin-like feature in E. coli and a 
lack of signal peptide for extracellular secretion regarding TcdA and TcdB (Von Eichel-
Streiber and Sauerborn, 1990).    
The question, however, cannot appropriately be addressed without a specific functional 
genetic knockout, a technique that was not established at that time for Gram positive 
bacteria. 
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2. Aim of the thesis 
 
The small open reading frame tcdE within the pathogenicity locus of Clostridium difficile is 
located between the genes for the pathogenic toxins TcdA and TcdB. Function and mode of 
action of the putative hydrophobic protein TcdE are unknown so far. Since no export 
mechanism for TcdA and TcdB is known and sequence homologies between TcdE and 
bacteriophage encoded holins were identified TcdE is supposed to facilitate release of the 
toxins from C. difficile into the extracellular environment. Alternatively, TcdE is hypothesized 
to be involved in colonization of C. difficile by affecting intestinal commensals or to act as an 
additional pathogenicity factor. The question of TcdE function cannot appropriately be 
addressed without a functional specific genetic knockout, a technique which was established 
no more than a few years ago. 
 
The aim of this study was to identify a regulatory or pathogenic impact of TcdE and to 
evaluate its role in C. difficile virulence. Therefore, the following aspects were investigated:  
Structure-function relationship of TcdE. TcdE deletion mutants have to be generated. The 
functional outcome of expression in E. coli has to be analyzed to identify functional domains 
of the protein. Furthermore, the putative holin-like dual start motif has to be mutated to 
examine its role in TcdE specific mode of action. 
Investigation of a potential pathogenic impact. To evaluate the role of TcdE in C. difficile 
pathogenicity, the influence of TcdE on isolated epithelial mitochondria and on the intact cell 
system have to be analyzed. 
Consequences of TcdE knockout in C. difficile. Insertional inactivation of tcdE has to be 
performed to analyze alterations in C. difficile specific characteristics with respect to 
bacterial growth, sporogenesis and toxin release. The specific TcdE knockout reveals 
unambiguous information about involvement of TcdE in virulence.   
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3. Materials and methods 
 
3.1 Materials 
 
T7 Express lysY/Iq Competent Escherichia coli (New England Biolabs); pQE30 vector (Qiagen, 
Germany); pcDNA3.1 vector (Invitrogen); pMTL007C-E2 (kindly provided by N. Minton, 
University of Nottingham); Oligonucleotides were synthesized by Operon, Germany; 
QuickChange XL site-directed mutagenesis kit (Stratagene, Germany); Restriction 
endonucleases, T4 DNA ligase and alkaline phosphatase were purchased from New England 
Biolabs; Pwo-Polymerase from Peqlab Biotechnologie GmbH (Germany); Fugene HD 
transfection reagent was from Roche (Germany); cell culture supernatant of α-myc secreting 
hybridoma cells was kindly provided by B. Sodeik (Institute of Virology, Hannover Medical 
School); Alexa Fluor 568 conjugated phalloidin was purchased from Molecular Probes (OR, 
USA); peroxidase-conjugated goat anti-rabbit IgG (Rockland, PA, USA);  
 
antigen host monoclonal company/ source 
 
TcdA 
TcdB 
TcdE (aa 134-166) 
cytochrome c 
cleaved caspase-3 
myc 
 
rabbit 
rabbit 
rabbit 
mouse 
rabbit 
mouse 
 
no 
no 
no 
yes 
yes 
yes 
 
Institute of Toxicology, MHH 
Institute of Toxicology, MHH 
this study 
BD Biosciences Pharmingen, NJ, USA 
Cell Signalling, MA, USA 
kindly provided by B. Sodeik (Institute 
of Virology, Hannover Medical School) 
 
 
Tab. 3.1. Primary antibodies  
 
host animal conjugated company 
 
goat 
goat 
goat 
goat 
 
rabbit 
mouse 
rabbit 
mouse 
 
peroxidase 
peroxidase 
Alexa Fluor 555 
Alexa Fluor 488 
 
Rockland, PA, USA 
Rockland, PA, USA 
Molecular Probes, OR, USA 
Molecular Probes, OR, USA 
 
 
Tab. 3.2. Secondary antibodies  
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3.2 Methods 
 
3.2.1 Microbiological methods 
 
3.2.1.1 Bacterial strains and culture 
 
Clostridium difficile strains VPI10463 (Accession-No. X92982), 1470, 630 (Acc.-No. 
AM180355), 630∆tcdE-234a (this study) and the hypervirulent strain 196 (Acc.-No. L76081) 
were grown in Brain Heart Infusion (BHI) broth at 37°C in an anaerobic gas jar.  
T7 Express lysY/Iq Competent Escherichia coli serving as cloning and expression hosts, 
respectively, were grown in Luria-Bertani (LB) medium supplemented with ampicillin (100 
mg/L).  
 
 
3.2.1.2 Generation of bacteria growth profiles 
 
Transformed E. coli or different C. difficile strains were grown in their respective media. At 
indicated time points 750 µl of liquid culture were taken and subjected to photometry to 
determine the optical density at 600 nm (OD600). The photometer was calibrated to OD600 = 1 
corresponding to 5 x 108 cells per ml. 
 
 
3.2.1.3 C. difficile cultivation and toxin expression 
 
(A) 10 ml scale 
Overnight cultures of C. difficile were pelleted and resuspended in fresh BHI broth to exclude 
distortion by toxins and spores at the initial values. The main culture was then inoculated 
with bacteria suspension with a volume calibrated to the respective optical density. The 
different C. difficile strains were cultivated for 0, 8, 24, 48 and 72 h and 10 ml of bacteria 
culture were pelleted at the respective time point by centrifugation for 10 min at 4,000 g. 
The supernatants were collected and chloroform methanol precipitation of 800 µl was 
performed according to Wessel and Flugge et al. (1984). Finally, the entire protein pellet 
harbouring the toxins A and B were solubilised in 50 µl PBS, sonicated (1 x 5 s, Cycle 50 %, 
Power 10 %) and laced with 5 x Lämmli. Protein solution was bisected and subjected to SDS-
PAGE and Western blot analysis to detect the TcdA and TcdB contents. The bacteria pellet 
containing TcdE was solubilised in 150 µl PBS supplemented with 5 mg/ml lysozyme and 1 
mM AEBSF and sonicated (1 x 1 min, Cycle 90 %, Power 40 %) after incubation for 1 h at 
37°C. Finally, the lysate was subjected to SDS-PAGE after calibration to the respective optical 
densities at time point of harvest. Western blot analysis with α-TcdE enabled the detection 
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of TcdE levels in a time dependent manner. Kodak software was used for densitometric 
analysis. 
 
 
(B) 500 ml scale 
500 ml BHI was inoculated either with C. difficile strain 630∆erm or with the TcdE-knockout 
strain cdi630∆tcdE and cultivated for 24 h. Bacteria were harvested by centrifugation at 
7,000 g for 20 min and lysed in 10 ml 50 mM Tris-HCl (pH 8.0), 2 mM MgCl2, 10 % glycerol, 2 
mM dithiotreitol (DTT) and 1 mM AEBSF using French Press. Following centrifugation at 
15,000 g for 20 min pelleted cell debris was resuspended in 2 ml lysis buffer mentioned 
above, supplemented with 2 % Triton X-100 and incubated for 30 min at 4°C to solubilise 
TcdE. 5 x Lämmli was added to 10 µl of suspension and SDS-PAGE and Western blot analysis 
with α-TcdE were performed.   
 
 
3.2.1.4 Gram staining of C. difficile 
 
The different strains of C. difficile were cultivated for 0, 8, 24, 48 and 72 hours. 500 µl of the 
cells were pelleted by centrifugation at 10,000 g for 2 min. After discarding the supernatants 
the pellets were solubilised in 20 µl BHI broth and streaked on glass slides. Afterwards, Gram 
staining was performed according to Lillie (1977) and the sections were subjected to light 
microscopy. 
 
 
3.2.1.5 Generation of a TcdE deficient C. difficile mutant 
 
The tcdE gene in C. difficile strain 630∆erm (Hussain et al., 2005) was disrupted by directed 
insertional inactivation using a bacterial group II intron according to Heap et al. (2007). In 
brief, one-tube SOE PCR (Splicing by Overlap Extension PCR) was performed to amplify a 
353 bp product containing the modified IBS, EBS1d and EBS2 sequences which are specific 
for the taget gene tcdE and  responsible for intron targeting. The target sites were identified 
and specific intron re-targeting primers were designed by means of a computer algorithm 
(Perutka et al., 2004) which is part of the Targetron Gene Knockout system kit 
(http://www.sigmaaldrich.com). The following primers were used: IBS: AAAAAAGCTTAT 
AATTATCCTTAAATATCCATGCTGTGCGCCCAGATAGGGTG; EBS1d: CAGATTGTACAA 
ATGTGGTGATAACAGATAAGTCCATGCTATTAACTTACCTTTCTTTGT; EBS2: TGAACGC 
AAGTTTCTAATTTCGATTATATTTCGATAGAGGAAAGTGTCT. The amplified targeting 
region was ligated via HindIII and BsrGI restriction sites into the plasmid pMTL007C-E2 and 
transformed in E. coli donor CA434. Plasmid pMTL007C-E2 exhibits a Retrotransposition-
activated selectable marker (RAM) coding for an erythromycin resistance which is activated 
after successful integration of the modified intron into the right target site. The retargeted 
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intron, named pMTL007C-E2:cdi-tcdE-234a according to the existing convention (Karberg et 
al., 2001), was then transferred in C. difficile 630∆erm via conjugation. Classification “234a” 
indicates insertion of the modified intron at position 234 of the tcdE gene in antisense 
direction. Finally, the transconjugants were re-streaked on BHI plates supplemented with 
2.5 µg/ml erythromycin to select for integrants and 250 µg/ml cycloserine and 8 µg/ml 
cefoxitin to select against the E. coli donor.  
 
 
 
3.2.2 Molecular biological methods 
 
3.2.2.1 Generation of TcdE constructs 
 
 The tcdE gene was amplified from C. difficile (VPI 10463, Accession No. X92982 ) genomic 
DNA using the primers listed in Tab. 3.3 and Tab. 3.4. PCR was performed in 50 µl with 
200 ng DNA, 300 nM of each primer, 250 µM dNTPs, 1x complete reaction buffer for Pwo 
polymerase and 2.5 U Pwo DNA Polymerase. The PCR conditions were the following: one 
initial cycle for denaturation at 95°C for 1 min, 28 cycles of denaturation at 95°C for 15 s, 
annealing at 55°C for 30 s and extension at 70°C for 1 min followed by a final extension 
phase at 70°C for 10 min. The PCR products were digested by BamHI and HindIII (pQE30) 
respectively XhoI and BamHI (pcDNA3.1) and then inserted into the corresponding plasmid 
vectors. Transformation and protein expression occurred in T7 Express lysY/Iq competent 
E. coli. A fusion construct of N- and C-terminus (TcdE NC) was generated on the basis of 
commercial oligonucleotides which were ligated successively in pQE30 connected by a 
glycine linker.  
 
 
Tab.3.3: Primers used for cloning into pcDNA3.1 vector 
 
 
 
 
 
 
 
 
Primer bp Sequence 
TcdE wt (s) 
TcdE wt (a) 
1-501 
5’ AGTCACTCGAGCGATGCACAGTAGTTCACCTTTTTATATTTC 
5’ AGTCGGATCCCTTTTCACCCTTAGCATTCATTTCATC 
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Primer bp Sequence 
TcdE wt (s) 
TcdE wt (a) 
1-501 
5’AGTCGGATCCATGCACAGTAGTTCACCTTTTTATATTTC 
5’AGTCAAGCTTCTTTTCACCCTTAGCATTCATTTCATC 
TcdE∆N (s) 
TcdE∆N (a) 
79-501 
5’AGTCGGATCCATGACAATATCTTTTTTATCAG  
5’AGTCAAGCTTCTTTTCACCCTTAGCATTCATTTCATC 
TcdE∆C (s) 
TcdE∆C (a) 
1-397 
5’AGTCGGATCCATGCACAGTAGTTCACCTTTTTATATTTC  
5’AGTCAAGCTTCTACATATTTTTTTAATATACTTACACTTTCATA  
TcdE∆N∆C (s) 
TcdE∆N∆C (a) 
79-397 
5’AGTCGGATCCATGACAATATCTTTTTTATCAG  
5’AGTCAAGCTTCTACATATTTTTTTAATATACTTACACTTTCATA  
TcdE N (s) 
 
TcdE N (a) 
1-79 
5’GATCAATGCACAGTAGTTCACCTTTATATTTTAATGGTAACAAAAT
ATTTTTTTATATAAACCTAGGGGGCGTTATGAATATGGGTGGTGGTGG
TGGATCCGGTGGTAAGCTTT 
5’AGCTAAAGCTTACCACCGGATCCACCACCACCACCCATATTCATAA
CGCCCCCTAGGTTTATATAAAAAAATATTTTGTTACCATTAAAATATA
AAGGTGAACTACTGTGCATT 
TcdE C (s) 
 
TcdE C (a) 
397-501 
5’GATCTAATATGTGCTTATGTGGATTACCAGTACCTAAGAGATTAAA
GGAAAAAATAGTAGTTTTACTAGATGCAATGACAGATGAAATGAATGC
TAAGGGTGAAAAGGGATCCGGTGGTAAGCTTT  
5’AGCTAAAGCTTACCACCGGATCCCTTTTCACCCTTAGCATTCATTT
CATCTGTCATTGCATCTAGTAAAACTACTATTTTTTCCTTTAATCTCT
TAGGTACTGGTAATCCACATAAGCACATATA  
 
Tab. 3.4: Primers used for cloning into pQE30 vector 
 
 
 
 
3.2.2.2 Generation of an N-terminal deletion mutant pcDNA3.1-TcdE∆N in a 
single cloning step 
 
The generation of the N-terminal deletion mutant pcDNA3.1-TcdE∆N was performed in a 
single cloning step according to Makarova et al. (2000). The PCR was accomplished in 50 µl 
with 100 ng pcDNA3.1-TcdE as DNA template, 200 nM of each primer (Tab. 3.5.), 200 µM 
dNTPs, 1x buffer for Pfu Polymerase and 2.5 U Pfu DNA Polymerase. The following PCR 
conditions were used: one initial cycle for denaturation at 95°C for 3 min, 18 cycles of 
denaturation at 95°C for 15 s, annealing at 65°C for 1 min and extension phase at 68°C for 
12 min followed by a final extension at 68°C for 15 min. Finally, digestion of methylated 
parental DNA with 1 µl Dpn I (10 U/µl) for 1 h at 37°C occurred followed by transformation in 
T7 Express lysY/Iq competent E. coli.    
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Primer bp Sequence 
TcdE∆N (s) 
TcdE∆N (a) 79-501 
5’CGGGCCCTCTAGACTCGAGCGATGACAATATCTTTTTTATCAGAGCATA 
5’TATGCTCTGATAAAAAAGATATTGTCATCGCTCGAGTCTAGAGGGCCCG 
 
Tab. 3.5: Primers used for generation of pcDNA3.1-TcdE∆N in a single cloning step 
 
 
3.2.2.3 Site-directed mutagenesis 
 
Site-directed mutagenesis within the Shine-Dalgarno sequence or start codons of TcdE was 
performed to investigate a putative dual start motif. Mutagenesis was carried out as 
described by the manufacturer’s instructions. The applied primers are listed in Tab. 3.6. 
Wildtype TcdE in pQE30 was used as template for PCR. 
 
 
Primer 
Short 
name 
Sequence 
TcdE G22L (s) 
TcdE G22L (a) 
SD I 
5’ATATAAACCTATTAGGCGTTATGAATATGACAATATC 
5’GATATTGTCATATTCATAACGCCTAATAGGTTTATAT 
TcdE G22L G23V (s) 
TcdE G22L G23V (a) 
SD II 
5’ATATAAACCTATTAGTCGTTATGAATATGACAATATC 
5’GATATTGTCATATTCATAACGACTAATAGGTTTATAT 
TcdE M25A M27C (s) 
TcdE M25A M27C (a) 
Met 
5’CCTAGGAGGCGTTGCGAATTGCACAATATCTTTTTTATC 
5’GATAAAAAAGATATTGTGCAATTCGCAACGCCTCCTAGG 
 
Tab. 3.6: Primers used for site-directed mutagenesis 
 
 
3.2.3 Biochemical methods 
 
3.2.3.1 Expression of recombinant protein 
 
 (A) 50 ml scale  
50 ml E. coli cultures carrying the indicated plasmids were grown at 37°C with shaking at 
175 rpm until the OD600 was 0.5. Protein expression was induced by the addition of 1 mM 
isopropyl-β-D-thiogalactoside (IPTG). Growth profiles were monitored for up to 6 h 
respectively 24 h by measuring the OD600. For time-course analysis of protein expression 1.5 
ml samples were harvested at different time points and pelleted by centrifugation at 
10,000 g for 2 minutes. The supernatant was discarded and the pellet was resuspended in 
100 µl of 1 x Lämmli supplemented with 1 mM 4-(2- Aminoethyl)-benzensulfonylfluorid 
(AEBSF). 
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(B) 1l scale 
T7 Express lysY/Iq competent E. coli harbouring the vector plasmid or its derivatives 
pQE30-TcdE and pQE30-TcdE∆N were cultivated in 1 l scale and induced as described above. 
After 1 h expression bacteria were pelleted at 7,000 g for 20 min and lysed in 50 mM Tris-HCl 
(pH 8.0), 2 mM MgCl2, 10 % glycerol, 2 mM dithiotreitol (DTT) and 1 mM AEBSF using French 
Press. The bacterial lysate was centrifuged at 15,000 g for 30 min to pellet the cell debris. 
The supernatant containing the soluble fraction of TcdE was sterile filtered (0.22 µm) and 
directly used for cytochrome c release assay. 
 
 
3.2.3.2 Generation of specific antibody 
 
The TcdE C-terminus DNA (397-498 bp) was cloned in pQE30 3-fold in succession linked by 
glycine residues and expressed in T7 Express lysY/Iq competent E. coli. Immunization of a 
female newzeeland rabbit was performed after standard protocol using affinity purified 
immunogen (amino acid sequence: MCLCGLPVPKRLKEKIVVLLDAMTDEMNAKGEKGGG 
MCLCGLPVPKRLKEKIVVLLDAMTDEMNAKGEKGGGMCLCGLPVPKRLKEKIVVLLDTDE
MNAKGEK) in Freud’s adjuvant. First immunisation was performed with 100 µg of protein 
followed by a single boost after four weeks. Blood was collected three weeks after boost 
immunisation. Specificity of anti-serum was checked by Western blot using the antigen as 
control (Permission No. 33-42502-03A351).  
 
 
3.2.3.3 Isolation of mitochondria and cytochrome c release- assay 
 
Mitochondria of Hep2 cells were isolated by differential centrifugation as described by 
(Perfettini et al., 2002). Hep2 cells were harvested in sucrose buffer (210 mM mannitol, 
70 mM sucrose, 1 mM EDTA, 10 mM Hepes (pH 7.5), 100 µM AEBSF, 10 µg/ml leupeptin, 
2 µg/ml aprotinin) transferred into a reaction tube and solubilized on ice by repeated suction 
through a syringe (0.8 x 44 mm). The homogenate was centrifuged at 500 g for 5 min at 4°C 
to separate mitochondria and larger cell components. The supernatant was used for 
preparation of the mitochondria enriched fraction by centrifugation at 10,000 g for 30 min at 
4°C. The pellet containing the mitochondria was resuspended in 150 µl sucrose buffer to 
perform cytochrome c release-assay. Therefore, mitochondria suspension was incubated 
with an equal volume of the soluble fraction of TcdE, TcdE∆N and of vector transformed 
cells, respectively. Following incubation for 2 h at 30°C mitochondria were pelleted at 
16,000 g for 15 min. Supernatant and resuspended mitochondria were subjected to SDS-
PAGE and Western blot analysis with cytochrome c-antibody to detect the ratio of 
cytochrome c in mitochondria and supernatant. 
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3.2.3.4 ATP determination assay 
 
The ATP determination kit (A22066) by Molecular Probes™ was used to detect ATP released 
from E. coli as a result of bacteriolysis. The bioluminescence assay is based on the reaction of 
ATP with recombinant firefly luciferase and its substrate luciferin.  
The assay was performed according to the manufactor’s instructions. In brief, in a 3- fold 
approach 90 µl of a standard reaction solution containing 25 mM Tricine buffer (pH 7.8), 
5 mM MgSO4, 100 µM EDTA, 100 µM sodium azide, 500 µM D-luciferin, 1 µM dithiothreitol 
(DTT) and 1.25 µg/ml firefly luciferase were combined in a 96-well with 10 µl supernatant of 
E. coli expressing either TcdE or the TcdE mutant Met, respectively. The supernatants were 
collected 3 h after induction with 1 mM IPTG by spinning 200 µl bacteria culture at 16,000 g 
for 5 min. Luminescence was monitored after 15 min incubation at 28°C using a Biotek 
Synergy luminometer. 
 
 
3.2.3.5 Cytotoxicity assay 
 
Hep2 cells were grown on 24 well chambers for 24 h and exposed to supernatants of the 
C. difficile strains cdi630∆erm and the TcdE-knockout strain cdi630∆tcdE cultivated for 48 h 
containing the native toxins A and B. Immediately after toxin treatment (0h) and after 
incubation for 2 h at 37°C cells were subjected to light microscopy and cytopathic effect was 
quantified as rounded cells per total cells in %. Each result is based on ten independent 
samples. Values are given as means ± standard deviations. 
 
 
 
3.2.4 Immunological methods 
 
3.2.4.1 SDS-PAGE and Western blotting 
 
Protein samples were separated by SDS-PAGE and transferred onto a nitrocellulose 
membrane using “semi-dry” techniques (17 V, 72 min). After blocking of unspecific binding 
with 3 % (w/v) bovine serum albumine and 2 % (w/v) nonfat dry milk in TBST (50 mM 
Tris HCl, 150 mM NaCl, 0.05% (v/v) Tween 20, pH 7.2) the membrane was incubated 
overnight with the respective primary antibody (Tab. 3.1) in blocking solution at 4°C. After 
washing thoroughly with TBST, horseradish peroxidase conjugated secondary antibody (Tab. 
3.2) was applied for 45 min at RT. Detection was performed by chemiluminescence (Super 
Signal West Femto, Pierce). KODAK 1D software was used for densitometric analysis. 
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3.2.4.2 Transfection and immunofluorescence 
 
Hep2 cells were grown on coverslips and plasmid vector pcDNA3.1 or its derivatives 
pcDNA3.1-TcdE or pcDNA3.1-TcdE∆N were transfected with Fugene HD according to the 
manufactor’s instructions. Twenty-four hours post-transfection, cells were washed with PBS, 
fixed with 4 % paraformaldehyde/sucrose solution and permeabilized for 5 min with 0.2 % 
Triton X-100 in PBS. After washing with PBS the coverslips were blocked for 1 h with 10 % 
BSA in PBS and stained with cleaved caspase-3 antibody (1 : 400 in 1 % BSA in PBS) for 1 h 
followed by staining with Alexa Fluor 555 conjugated goat anti-rabbit secondary antibody 
(1 : 200 in 1 % BSA in PBS) for 45 min. After washing with 1 % BSA in PBS second 
immunofluorescence staining was performed. Therefore cells were incubated with cell 
culture supernatant of α-myc secreting hybridoma cells for 1 hour at room temperature 
followed by staining with oregon green conjugated goat anti-mouse secondary antibody 
(1:2000 in 1 % BSA in PBS) for 45 min. Simultaneously, nuclei were counterstained with DAPI. 
Filamentous actin was labelled with Alexa Fluor 568 conjugated phalloidin for 45 min 
(500 nM). Finally, the coverslips were mounted onto glass slides and subjected to confocal 
laser scanning microscopy (Leica Inverted DM IRE 2). Additionally, control cells were treated 
15 h with 1 µm of the protein kinase inhibitor staurosporin which induces apoptosis by 
activating caspase-3. 
 
 
 
3.2.5 Cell biological methods 
 
3.2.5.1 Cell culture 
 
The human epithelial larynx carcinoma cell line (Hep2) was cultivated under standard 
conditions in Minimal Essential Medium (MEM) with Earle’s Salts and L-Glutamine 
supplemented with 10 % foetal bovine serum (FBS), 100 µM penicillin and 100 µg/ml 
streptomycin. The cell line was subcultured twice a week. Therefore they were washed once 
in PBS and incubated in Trypsin-EDTA solution for 5-10 min at 37°C to release the cells. 
Subsequent to resuspension in their culture medium cells were seeded in flasks or, for 
transfection experiments, on coverslips in 24 well chambers, respectively. 
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4. Results 
 
4.1 Influence of Clostridium difficile TcdE on bacteria 
 
4.1.1 TcdE induces lysis of E. coli 
 
Function and mode of action of Clostridium difficile TcdE are unknown. TcdE shows sequence 
homologies and structural similarities to bacteriophage encoded holins which oligomerize 
within the host cell membrane forming lethal holes causing cell death of bacteria. Growth 
profiles of E. coli expressing wildtype TcdE were monitored to study TcdE- induced effects on 
bacteria. TcdE expression in E. coli resulted in a sudden loss of culture turbidity subsequently 
after induction indicating at least a growth inhibiting capacity of TcdE on bacteria. This 
phenomenon was not observed in E. coli transformed with the control vector (Fig. 3.1 [A]).  
Western blot analysis with specific anti-TcdE serum confirmed the expression of 19 kDa TcdE 
in induced E. coli. Interestingly, an additional 16 kDa protein was detected with a 10-fold 
higher expression level than the full length protein (Fig. 3.1 [B]). 
 
 
 
 
 
Fig. 4.1: TcdE expression inhibits bacterial growth. [A] The expression of TcdE in Escherichia coli resulted in a sudden halt 
of bacterial growth. Gradual loss of culture turbidity was observed which was not observed in E. coli transformed with 
empty vector. [B] Western blot analysis with α-TcdE confirmed the expression of full length TcdE (19 kDa) in induced E. coli 
after 1 h. Additional a 16 kDa protein was detected with a 10-fold excess.      
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 As sequence analysis showed, tcdE mRNA exhibits two additional AUG start codons 
contributing to amino acids 25 and 27. The deduced molecular weights of the putative 
proteins initiating from the first and third start codons are 19 kDa and 16 kDa, respectively. 
Since holins utilize a dual start motif to produce proteins of different length and function, 
the expression pattern of TcdE might indicate a similar mechanism. To investigate this 
hypothesis mutational analysis was performed (Section 4.1.3). 
The strong decrease of the optical density to almost 30 % of the initial value implicated 
bacterial cell lysis. A sensitive method to determine disruption of bacteria is the detection of 
released ATP in terms of luminescence. Supernatants of E. coli expressing either the empty 
vector or wildtype TcdE for 3 hours were applied to the ATP determination assay. TcdE 
induced a 10- fold higher ATP release compared to the empty vector which reflected 
bacteriolysis in consequence of TcdE expression.  
Thus, this result confirms a TcdE mediated bacteriolysis.  
 
                             
 
Fig. 4.2: TcdE expression induces bacteriolysis. ATP release from E. coli expressing wildtype TcdE was used for detection of 
bacteriolysis. Supernatants were collected three hours post induction and subjected to ATP determination assay. 
Luminometry was performed to monitor released ATP. The data verified a TcdE- induced lysis of bacteria according to a 
tenfold higher ATP-release compared to the vector control. The values are expressed as means ± standard deviation (n=3). 
 
 
 
4.1.2 The hydrophobic transmembrane domains are essential for 
TcdE-induced growth inhibition of bacteria 
 
To investigate putative functional domains for the bacteriolytic property deletion mutants of 
TcdE were generated. The N-terminal deletion mutant TcdE∆N lacks the N-terminus and 
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TcdE∆N∆C only consists of the three transmembrane domains. TcdENC reflects a fusion 
protein of the N- and the C-terminal domains (Fig. 4.3). 
 
 
 
 
Fig. 4.3: Scheme of TcdE deletion mutants. Wildtype TcdE (TcdE wt) exhibits three transmembrane domains, a hydrophilic 
N-terminus (aa 1-26) and a highly charged C-terminus (aa 133-166). The N-terminal deletion mutant TcdE ∆N lacks the N-
terminal region and TcdE∆C accordingly the C-terminus. TcdE∆N∆C only consists of the three transmembrane domains and 
TcdENC reflects a fusion protein of the N- and the C-terminal domains. 
 
 
Fig. 4.4 shows the growth profiles of E. coli expressing wildtype TcdE and the respective 
mutants. As described above, wildtype TcdE (Fig. 4.4, red squares) induced bacteriolysis 
monitored by a continuous decrease in optical density following induction. This 
phenomenon was not observed in E. coli transformed with empty vector (Fig. 4.4, black 
squares). The N-terminal deletion mutant TcdE∆N (Fig. 4.4, blue squares) showed similar 
effect to that of wildtype TcdE although the OD600-decrease was less pronounced. The fusion 
protein TcdENC (Fig. 4.4, yellow squares), consisting of the N- and C-terminal regions, did not 
affect bacterial growth compared to the vector control indicating an essential role for the 
hydrophobic transmembrane domains of TcdE concerning growth inhibiting. To investigate 
this hypothesis TcdE mutant ∆N∆C, harbouring only the three transmembrane domains, was 
expressed. In fact, the expression of TcdE∆N∆C (Fig. 4.4, green squares) resulted in 
immediate inhibition of bacterial growth. Optical density stagnated at a constant level of 
OD600 = 0.4 for at least 5 h following induction revealing the transmembrane domains to be 
sufficient in inhibition of E. coli growth. A C-terminal deletion mutant TcdE∆C was also 
generated which expression led to an identical growth profile with a congruently developing 
curve to that of TcdE∆N∆C (not shown). Western blots with α-tcdE antibody confirmed the 
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expression of wildtype TcdE, TcdE∆N and TcdENC, respectively. Since the TcdE antibody is 
directed towards the C-terminus of the protein, a method to detect the deletion mutant 
TcdE∆N∆C was unfortunately missing. 
 
 
 
Fig. 4.4: The hydrophobic transmembrane domains are essential for TcdE-induced inhibition of bacterial growth. [A] 
Growth profiles of E. coli expressing wildtype TcdE and TcdE deletion mutants were monitored to further investigate 
functional domains of the protein. The N-terminal deletion mutant ∆N (blue) lacks the N-terminal region. ∆N∆C only 
consists of the three transmembrane domains (green) and NC reflects a fusion protein of the N- and the C-terminal domains 
(yellow). As described, optical density of E. coli expressing wildtype TcdE (red) decreased continuously following induction 
to a value of 0.2. The curve referring to TcdE∆N reflected a similar development, however, only a marginal transient 
decrease of the optical density was observed. The fusion protein NC did not affect bacterial growth compared to the growth 
profile of E. coli transformed with empty vector (black). Since this observation indicated an essential role for the 
transmembrane domains concerning inhibitory effects, growth curves of E. coli expressing TcdE∆N∆C were monitored. In 
fact, the hydrophobic transmembrane domains resulted in immediate stagnation of bacterial growth to a constant 
OD600 = 0.4 up to 5 h following induction. A C-terminal deletion mutant caused an identical growth profile (not shown). 
Values are given as means (n=3). [B] Western blot analysis with α-TcdE confirmed IPTG-induced expression of wildtype 
TcdE, TcdE∆N and TcdENC, respectively, after 1 h. The respective molecular weights are indicated. Evidence of TcdE∆N∆C 
expression was missing since TcdE antibody was directed towards the C-terminus.  
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4.1.3 The ratio of full length to truncated TcdE is regulated by a 
dual start motif 
 
Many holins exhibit two start codons separated by one amino acid residue resulting in the 
expression of two proteins with different length and opposing function, acting as either a 
holin or as its inhibitor. The tcdE gene exhibits two additional start codons contributing to 
amino acids 25 and 27. Interestingly, DNA sequence analysis also indicated an alternative 
ribosome binding site (Shine-Dalgarno sequence AGGAGGC) upstream of the second and 
third start codons (Dove et al., 1990). The deduced molecular weights of the proteins 
initiating from the first and from the third start codon are 19 kDa and 16 kDa, respectively.  
To investigate the putative dual start motif site-directed mutagenesis was performed to 
generate point mutations within the Shine-Dalgarno sequence (SD I and SD II) or the start 
codons itself (Met), respectively.  
 
 
 
 
Fig. 4.5: Investigation of a putative dual start motif by using TcdE mutants. The N-terminal part of TcdE mRNA reflects 
three start codons AUG (blue, dashed) and a putative Shine-Dalgarno sequence (black, underlined) enabling the expression 
of protein of different length. Site-directed mutagenesis was performed to generate mutations within the Shine-Dalgarno 
sequence and the start codons, respectively (red). The Shine-Dalgarno mutants exhibit two (SD I) or rather three (SD II) 
point mutations reducing translation initiation at the following two start condons. The Methionine-mutant (Met) exhibiting 
point mutations in both start codons was generated to completely prevent translation initiation at the 2. and 3. start 
codons leading to full length TcdE, exclusively. The numbers above the mRNA sequence express the respective base pairs 
(bp). 
 
 
Wildtype TcdE and the mutants were expressed in E. coli and Western blot analysis with 
specific anti-TcdE serum was performed showing strong expression already 0.5 h upon 
induction. The expression pattern of wildtype TcdE reflected a full length 19 kDa and an 
N-terminal shortened 16 kDa protein (Fig. 4.6, 1st panel). This observation was in accordance 
  4. Results 
  26 
with the deduced molecular weights of the proteins initiating from the first and the third 
start codons, respectively. Sequential mutation of base pairs within the putative Shine-
Dalgarno sequence (Fig. 4.5, TcdE G22L [SD I] and TcdE G22LG23V [SD II]) shifted the ratio of 
full-length (19 kDa) to truncated (16 kDa) TcdE from 1 : 9 to approximately 4 : 6 (Fig. 4.6). 
This observation was a result of a reduced translation initiation at the third start codon 
confirming the existence of a functional dual start motif with respect to TcdE. Regarding the 
expression levels, wildtype TcdE can be considered as truncated 16 kDa TcdE. The 
Methionine-mutant (Fig. 4.5, TcdE M25AM27C [Met]) exhibits point mutations within the 2. 
and 3. start codons which completely prevented translation initiation leading to 19 kDa 
full length TcdE, exclusively (Fig. 4.6).  
 
 
 
 
Fig. 4.6:  The ratio of full length to truncated TcdE is regulated by a dual start motif. [A] Western Blot analysis with α–TcdE 
confirmed expression of full length TcdE and the respective mutants. The expression pattern of E. coli transformed either 
with full length TcdE or with the Shine-Dalgarno mutants (SD I, SD II) exhibited a 19 kDa and a 16 kDa protein. Expression of 
the Methionine-mutant reflected the full length TcdE, exclusively. [B] Densitometric analysis of protein expression after 
0,5 h revealed a shift of the ratio of truncated (16 kDa, black bars) to full length TcdE (19 kDa, white bars) from 10 : 1 to 
approximately 1.5 : 1 following sequential mutation of base pairs within the Shine-Dalgarno sequence.  
 
 
[B] 
[A] 
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The growth profiles of E. coli expressing TcdE and the Shine-Dalgarno mutants SD I and SD II 
(Fig. 4.7) showed a strong decrease of the OD600 from 0.6 to 0.2 within 2 hours. Interestingly, 
this phenomenon was independent on the ratio of full length to truncated TcdE since 
bacteriolysis induced by wildtype TcdE as well as by SD I and SD II acted on the same kinetic. 
In contrast, expression of exclusively the full length TcdE (TcdE Met) resulted in 
bacteriostasis since bacterial growth stagnated 2 hours following induction.  
 
 
 
Fig. 4.7:  Expression of wildtype TcdE and mutant TcdE in E. coli. The expression of full length TcdE (filled circles) and the 
Shine-Dalgarno mutants (SD I: filled squares, SD II: filled triangle) in E. coli resulted in a sudden loss of culture turbidity 
reflecting lysis of bacteria. The Met-mutant (open diamonds) induced bacteriostasis but not lysis. The recovery of the 
curves after 2 h concerning wildtype TcdE and SD-mutants is based on base insertions into TcdE DNA preventing expression 
of the active holin-like protein. In the case of the Met-mutant growth inhibitory of bacteria remains unaffected. 
 
 
The different behavior of wildtype TcdE and the Methionine-mutant with regarding growth 
inhibition or lysis of bacteria were investigated by the ATP release assay. Thus, ATP release 
from E. coli expressing wildtype TcdE or the Met-mutant was measured 3 hours after 
induction. The Methionine-mutant, reflecting the 19 kDa full length TcdE, induced marginal 
ATP release compared to the vector control. Wildtype TcdE, which can be equated with 
truncated TcdE with respect to the expression pattern, induced a threefold higher ATP 
release confirming the bacteriolytic properties of the truncated TcdE compared to the full 
length protein. 
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Fig. 4.8: Truncated TcdE but not full length TcdE induces bacteriolysis. Supernatants of E. coli expressing wildtype TcdE or 
the Methionine-mutant for 3 hours were subjected to ATP determination assay. Wildtype TcdE, due to expression of full 
length and truncated TcdE, induced a threefold higher ATP release (19550 ± 1900) than TcdE-Met expressing only full length 
TcdE. The Methionine-mutant caused a slight effect (5500 ± 103) compared to the vector control (2300 ± 985). Values are 
given as means ± standard deviation in arbitrary units.   
 
 
Regarding the growth profiles in Fig. 4.7 two hours after induction recovery of OD600 was 
observed. Unlike lysis, kinetic of recovery was different for wildtype TcdE and the respective 
mutants and thus, depended on the ratio of the full length to the truncated TcdE. While the 
optical density of E. coli expressing more than 90 % truncated TcdE (TcdE wt) started to 
recover after 2 hours, OD600-recovery of E. coli expressing only 60 % truncated and 40 % full 
length TcdE (TcdE SD II) showed a 2 hours delay. 24 hours following induction OD600 of E. coli 
expressing TcdE wt and SD I and SD II reached a same value of almost 3.0 whereas E. coli 
transformed with TcdE-Met showed only a slight increase up to an optical density of 1.5. 
DNA sequencing of single colonies expressing the different forms of TcdE excluded that this 
phenomenon was due to a loss of the plasmid harboring the tcdE construct. Rather, this 
observation was attributed to be based on base insertions into tcdE DNA accompanied by a 
disruption of the tcdE gene (Diploma thesis, S. Seehase). Western blot analysis displaying the 
protein levels in a time dependent manner confirmed the abortion of TcdE expression 5 
hours following induction. After 24 hours TcdE almost completely disappeared. This 
phenomenon was observed in E. coli expressing wildtype TcdE as well as the mutants SD II 
and Met and was obtained for the full length and the truncated protein.  
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Fig. 4.9:  TcdE- expression is aborted in a time-dependent manner. E. coli lysates expressing wildtype TcdE and the 
respective mutants (SD I and SD II, Met) were analyzed by Western blot using α–TcdE antiserum. A time-dependent 
abortion in expression of the full length and the truncated TcdE was observed for wildtype TcdE and the mutants SD II and 
Met. Cross reactive protein (35 kDa) was used as loading control and to exclude general protein degradation. 
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4.2 Investigation of a putative pathogenic role of Clostridium 
difficile TcdE  
 
4.2.1 TcdE does not induce cytochrome c release from isolated 
mitochondria 
 
It is still not clear whether C. difficile TcdE functions as a regulatory protein, a colonization 
factor or as a virulence factor. To investigate possible pathogenic properties isolated 
mitochondria of Hep2 cells were exposed to recombinant TcdE. As quantity for mitochondria 
disruption cytochrome c release was determined on the basis of Western blot analysis.  
 
 
Fig. 4.10: TcdE did not induce cytochrome c release from isolated mitochondria.  Isolated mitochondria of Hep2 cells were 
exposed to recombinant wildtype TcdE, exhibiting full length and truncated TcdE in a ratio 1 : 10, and the respective N-
terminal shortened form TcdE∆N. [A] On the basis of Western blot analysis cytochrome c release was checked. [B] 
Densitometric evaluation of Western blot analyses. Cytochrome c release induced by wildtype TcdE and TcdE∆N was 
11 % ± 1.9 % respectively 15 % ± 0.8 %. These values did not exceed background level (18 % ± 7 %) as indicated by the 
vector control. Triton X-100 served as positive control and induced cytochrome c release of 80 % ± 6 %. Values are given as 
means ± standard deviation (n=3).  
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As shown in Fig. 4.10, neither wildtype TcdE, reflecting the full length and the truncated 
protein products in a ratio 1 : 10, nor the N-terminal shortened form TcdE∆N induced 
cytochrom c release from mitochondria compared to the vector control. Background 
cytochrome c release of 11 % to 18 % was detected. Triton X-100 was used as positive 
control leading to 80 % ± 6 % of Cytochrome c in the supernatant. The data clearly show that 
TcdE did not induce mitochondria disruption. 
 
 
4.2.2 TcdE does not induce apoptosis in Hep2 cells 
 
To investigate a potential apoptotic effect Hep2 cells were transfected with the long and 
short TcdE. Cell morphology, actin cytoskeleton and activation of caspases-3 were examined 
by immunofluorescent staining. Transfection was performed with constructs harboring the 
full length tcdE gene or the N-terminal deleted gene tcdE∆N. In contrast to TcdE expression 
in bacteria, the eukaryotic expression system ensured production of exclusively full length 
TcdE when transfected with the full length construct since the eukaryotic translation 
apparatus does not utilize the prokaryotic alternative ribosome binding site. Thus, the 
system allowed distinguishing between full length and short TcdE.  
As shown by myc immunostaining, full length TcdE as well as the N-terminal shortened 
bacteriolytic product was distributed within the cytoplasm concentrated around the nucleus 
(Fig. 4.11 [A]+[B]). Interestingly, presence of TcdE protein within the cytoplasmic membrane 
was excluded as pointed out by merging the pictures of myc and phalloidin staining 
(Fig. 4.11  [A]). Two different types of protein distribution within the cell were monitored: 
TcdE and TcdE∆N accumulated in the cytoplasm in terms of ‘spots’ with dense areas around 
the nucleus (Fig. 4.11 [C], left panel). On the other hand, interweaved, “maze-like” structures 
also concentrated in the neighborhood of the nucleus became visible (Fig. 4.11 [C], right 
panel). The two types were observed following 24h and 48h expression of both, full length 
TcdE and the N-terminal deleted product TcdE∆N (only shown for full length TcdE). The 
expression of each form didn’t alter cell morphology nor induce fragmentation of DAPI 
stained nuclei after 24 h and 48 h (Fig. 4.11 [A], only shown for 48 h) indicating that TcdE 
does not affect viability of eukaryotic cells. Immunostaining against activated caspases-3 as 
an apoptotic marker confirmed this result since neither TcdE nor TcdE∆N activated caspase-
3 after 48 h expression. Staurosporin treated cells served as positive control for staining of 
activated caspase-3 (Fig. 4.11 [B]). The absence of an alteration of nucleus and cell 
morphology and of activated caspases speaks against the hypothesis of TcdE acting as 
pathogenic factor. 
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Fig. 4.11: TcdE is not involved in apoptosis. Hep2 cells grown on coverslips were transfected with full length TcdE, the N-
terminal deletion mutant TcdE∆N or the empty vector pcDNA3.1. 24 h and 48 h following transfection immunofluorescence 
staining was performed (only shown for 48h). [A] Positive transfected cells are shown by α-myc immunofluorescence 
staining. Neither expression of full length TcdE nor TcdE∆N affected the nuclei or cell morphology as shown by DAPI 
staining and rhodamin-phalloidin staining of the actin cytoskeleton. [B] Additionally, staining against activated caspases-3 
was performed. Neither TcdE nor TcdE∆N activated the apoptotic marker caspases-3. [C] Two different types of TcdE 
protein distribution were observed: protein accumulation forming “spots” (left panel) and interweaved “maze-like” 
structures (right panel).   
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4.3 Clostridium difficile specific characteristics 
 
4.3.1 Toxin expression by C. difficile strains VPI10463 and 196 
 
The hypothesis of TcdE to function as a release-factor for the pathogenic toxins TcdA and 
TcdB assumes a simultaneous expression of the three proteins. Western blot analysis 
displayed the protein levels of the pathogenic C. difficile strain VPI10463 and the 
hypervirulent PCR-ribotype 027 strain 196 in a time-dependent manner (Fig. 4.12 [A]). 
Densitometric evaluation of Western blot analysis of the reference strain cdi VPI10463 was 
performed to contrast TcdE expression with the appearance of TcdA and TcdB.  
 
 
 
 
Fig. 4.12: TcdE expression correlated with the appearance of the pathogenic toxins TcdA and TcdB. [A] The pathogenic 
C. difficile strain VPI10463 was cultured for 72 h and samples were taken at indicated time points. The membrane fractions 
were lysed and subjected to Western blot analysis to detect TcdE levels. Interestingly, exclusively the full length TcdE was 
expressed. The proteins of the respective supernatants were precipitated and Western blot analysis with specific TcdA or 
TcdB antibodies was performed. [B] Densitometric analysis of toxin expression of cdiVPI10463 revealed a temporal 
correlation between TcdE expression and the appearance of the toxins TcdA and TcdB. Protein levels are given in arbitrary 
units. 
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TcdE was expressed already after 7 h of cultivation. Levels increased up to 48 h reaching a 
plateau phase. Since the appearance of TcdE in the membrane fraction and accumulation of 
the respective glucosyltransferases TcdA and TcdB in the supernatant occurred 
simultaneously, the hypothesis of TcdE facilitating the release of the pathogenic toxins to the 
extracellular environment was supported. 
Interestingly, in difference to TcdE expression in E. coli exclusively the 19 kDa full length TcdE 
was detected in C. difficile. 
 
An interesting observation was the transient increase of the bacterial cell population with a 
maximum of OD600 at approximately 25 hours. The following reduction in the optical density 
to a value of 1 was accompanied by a considerable 4-fold increase in toxin expression, 
exemplified for TcdA. Hence, cell count and release of the pathogenic toxins TcdA/B 
correlated vice versa.  
 
 
 
 
Fig. 4.13: TcdA expression correlated vice versa with bacterial cell count. TcdA levels (black squares) are mapped towards 
the OD600 (grey circles) at the respective time points. A strong increase in bacteria count was accompanied by a slight TcdA 
expression. Following maximum in cell density the OD600 was reduced from 2 to 1 while the TcdA level increased 4-fold. 
TcdA levels, as analyzed by densitometrical evaluation of Western blot analysis, are given in arbitrary units. 
 
 
 
4.3.2 Sporulation of low and high toxin producing C. difficile strains 
 
Sporulation is one of the main characteristics of clostridia and of ecological advantage to the 
organism as it enables to survive under adverse conditions. Thus, sporulation occurs under 
condition of nutrient depletion which is present after long time culturing. To investigate 
whether TcdE is involved in C. difficile sporulation, TcdE expression and sporulation rates of 
different C. difficile strains were compared. Hence, Gram stain of liquid culture was used to 
visualize and examine sporulation. Fig. 4.14 illustrates the development of Gram positive 
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rods from 8 h to 72 h of cultivation exemplified for the hypervirulent C. difficile strain 196. 
During the logarithmic growth phase exclusively vegetative bacteria were observed 
characterized by a homogeneous distribution of the cristal violet stain (8 h). After 48 h of 
cultivation endospores became visible that developed within the rod and escaped the Gram 
stain. Time dependently, most of bacterial cells appeared Gram negative which was due to 
reconstruction processes inside the cell wall known for older Gram positive bacteria. 
 
     
 
Fig. 4.14:  Gram stain of C. difficile strain 196. At indicated time points samples of C. difficile liquid culture were taken and 
subjected to Gram staining. Time dependently, Gram positive rods became Gram negative due to reconstruction processes 
inside the cell wall. Furthermore, C. difficile formed endospores with one spore per cell displayed after 48 h of culturing. 
 
 
Sporulation rates of the C. difficile reference strain VPI10463, the variant strain 1470 serotype F and 
the hypervirulent strain 196 (PCR ribotype 027) were compared.  
 
 
 
Fig. 4.15: Comparative analysis of sporulation of C. difficile strains VPI10463, 1470 and 196. Samples of liquid cultures of 
the different strains at the respective time points were subjected to Gram staining to visualize spore formation. The high 
toxin producing strain VPI10463 showed a low sporulation rate of 5 % after 72 h. In contrast the hypervirulent strain 196 
and the variant strain 1470 started sporulation at earlier time points (24 h) and with higher values of almost 60 % after 72 h. 
Sporulation was quantitated as endospores per total bacterial cells and given in %. 
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Therefore, Gram stainings of the respective samples were performed and sporulation was quantified. 
As shown in Fig. 4.15 the high producer strain C. dificile VPI10463 exhibited a low sporulation efficacy 
of 5 % spores per total cells not until 72 h of cultivating. In contrast, 15 % of bacteria of the 
hypervirulent strain C. difficile 196 formed endospores already after 24 h and almost 60 % after 48 h. 
The results of the strain C. difficile 1470 serotype F were comparable to the hypervirulent strain and 
exhibited 60 % sporulation after 7 h. Thus, the toxin high producing C. difficile strain VPI10463 
exhibited a more than 10- fold less sporulation efficacy than the hypervirulent strain 196 and 
the variant strain 1470 serotype F. 
 
 
4.3.3 Comparative analysis of TcdE expression in low and high 
sporulating C. difficile strains 
 
To investigate whether TcdE is involved in the difference of the sporulation efficiencies 
between the hypervirulent 196 and the reference strain VPI10463 TcdE expression levels 
were determined. Therefore, lysates of clostridia were prepared at the indicated time points 
and Western blot analysis with polyclonal anti-TcdE antibody was performed.  
 
 
 
Fig. 4.16: Comparative analysis of TcdE expression in the reference strain C. difficile VPI10463 and the high sporulating 
hypervirulent strain C. difficile 196. [A] Western blot analysis of clostridia lysates with α-TcdE was performed to compare 
the TcdE levels in C. difficile strains VPI10463 and 196 in a time dependent manner. Therefore lysates were adjusted to 
bacterial cell count. [B] Densitometric analysis revealed an almost 5-fold excess of TcdE expression in reference strain 
VPI10463 (black squares) compared to the hypervirulent, high sporulating strain 196 (white squares). TcdE levels are given 
in arbitrary units. 
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The volume subjected to SDS-PAGE was adjusted to bacterial cell count allowing direct 
comparison of the immunoblots. Interestingly, among sporulation efficacies also TcdE levels 
differed in the reference strain VPI10463 compared to the hypervirulent strain 196. 
Densitometric analysis revealed an almost 5- fold excess of TcdE expression in the reference 
strain VPI10463 compared to the high sporulating C. difficile strain 196. 
 
 
4.4 Investigation of TcdE function via specific insertional 
inactivation of tcdE in Clostridium difficile strain 630∆erm  
 
4.4.1 Insertional inactivation of tcdE using the ClosTron method  
 
Splicing by Overlap Extension PCR (SOE PCR) was performed to amplify a 353 bp product 
containing the modified IBS, EBS1d and EBS2 sequences which are specific for the target 
gene tcdE and responsible for intron targeting (Fig. 4.17 [A]). The following HindIII and BsrGI 
digests prepared the PCR product for ligation into digested and purified plasmid 
pMTL007C-E2. An insertion of the 350 bp product into plasmid pMTL007C-E2 can be checked 
by PCR. A 560 bp band reflected positive ligation compared to a 440 bp band amplified from 
the digested plasmid alone (Fig. 4.17 [B]). Finally, construct pMTL007C-E2: Cdi-tcdE-234a was 
sequenced to verify correct insertion.  
 
 
 
Fig. 4.17: Generation of construct pMTL007C-E2: Cdi-tcdE-234a. [A] One-tube SOE-PCR (Splicing by Overlap Extension) was 
performed to amplify a 353 bp product containing the modified IBS, EBS1d and EBS2 which are responsible for intron 
targeting. HindIII and BsrGI restriction sites were generated followed by a purification step to prepare the insert for ligation. 
Agarose gel electrophoresis (1%) was used as detection method visualizing a specific 350 bp band. [B] Digested and 
purificated PCR-product was ligated over night at 16°C in plasmid pMTL007C-E2 which offers also the HindIII and BsrGI 
restriction sites. Positive ligation was checked by PCR followed by agarose gel electrophoresis (1 %). Correct insertion 
resulted in a 440 bp PCR product compared to the negative control pMTL007C-E2 with a 560 bp PCR product. 
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Subsequent to transformation of E. coli donor CA434 with construct 
pMTL007C-E2: Cdi-tcdE-234a, conjugation with the recipient C. difficile 630∆erm was 
performed. Afterwards, transconjugants were selected by antibiotics using erythromycin 
resistance which was acquired by intron insertion. Genomic DNA of selected transconjugants 
was isolated and PCR screening was performed to identify the desired knockout. 
Amplification of the intron-exon junction gave unambiguous information. As shown by 
agarose gel electrophoresis, the expected 449 bp PCR product was amplified in 16 out of 17 
clones. Plasmid pMTL007C-E2 and genomic DNA from the initial strain cdi630∆erm were 
used as negative controls. Finally, correct insertion was additionally ensured by sequencing.  
 
 
 
 
 
Fig. 4.18: PCR screening for gene knockout. PCR screening and following sequencing was used to unambiguously identify 
the desired insertional inactivation of the tcdE gene. An intron universal primer and a specific tcdE primer were used to 
amplify the intron-exon junction. An agarose gel (1%) displayed a 449 bp PCR product confirming intron insertion into the 
expected tcdE targeting region.  
 
 
 
4.4.2 Evidence of insertional inactivation of tcdE on protein level 
 
DNA-sequencing evidenced the successful insertional inactivation of the tcdE gene in 
C. difficile strain 630∆erm. Additionally, Western blot analysis was performed to confirm 
TcdE- knockout on protein level. Therefore, lysates of cdi630∆erm and cdi630∆tcdE were 
prepared after 24 h cultivation and the insoluble fraction was subjected to SDS-PAGE. 
Western blot analysis with TcdE antibody revealed strong expression of a 19 kDa protein in 
the reference strain cdi630∆erm which was not observed in the TcdE- knockout strain 
cdi630∆tcdE.  
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Fig. 4.19: Evidence of insertional inactivation of tcdE on protein level. Lysates of cdi630∆erm and cdi630∆tcdE after 24 h 
cultivation were prepared by means of mechanical cell disruption using the French Press. The insoluble membrane fraction 
was separated from the soluble fraction and resuspended in detergent containing buffer. Following incubation for 30 min at 
4°C the suspension was subjected to SDS-PAGE and Western blot analysis with α-TcdE. The reference strain cdi630∆erm 
obtained a strong expression of a 19 kDa protein which was not observed in the TcdE- knockout strain cdi630∆tcdE.  
 
 
 
4.4.3 Release of the pathogenic toxins TcdA and TcdB from mutant 
strain cdi630∆tcdE 
 
TcdE is supposed to participate in the release of the pathogenic toxins TcdA and TcdB. To 
investigate this hypothesis toxin release from C. difficile 630∆erm and the TcdE- knockout 
strain cdi630∆tcdE was compared. Therefore, supernatants of both strains were collected at 
indicated time points and precipitated proteins were subjected to SDS-PAGE and Western 
blot analysis with specific TcdA and TcdB antibodies. As shown in Fig. 4.20, Western blots 
reflected comparable toxin levels released from cdi630∆erm and cdi630∆tcdE with a slight 
increase regarding the mutant strain.  
 
                  
 
 
Fig. 4.20: Release of TcdA and TcdB from C. difficile strain 630∆erm and the TcdE-knockout strain cdi630∆tcdE. 
Supernatants of C. difficile strains cdi630∆erm and cdi630∆tcdE were collected at indicated time points and chloroform 
methanol precipitation was performed. Resuspended protein was subjected to SDS-PAGE (7.5 %) and Western blot analysis 
with specific TcdA and TcdB antibodies was performed. TcdE is not decisive involved in release of the pathogenic toxins 
since its knockout did not affect kinetic of toxin release nor absolute TcdA and TcdB levels.  
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In addition to the comparative analysis of the TcdA- and TcdB expression levels, functional 
assay was performed utilizing the toxin-induced cytopathic effect.  
 
 
 
           
 
Fig. 4.21: Cytopathic effect of Hep2 cells induced by C. difficile strain 630∆erm and the TcdE- knockout strain 
cdi630∆tcdE. [A] Hep2 cells grown in 24 well chambers were exposed to 250 µl supernatants of cdi630∆erm and 
cdi630∆tcdE cultivated for 48 h. Cell rounding was recorded by means of light microscopy 0 h and 2 h after addition of 
toxins. [B] Cytopathic effect was quantified as rounded cells per total cells in %. Supernatants of cdi630∆erm and 
cdi630∆tcdE caused 42 % ± 7 %, respectively 52 % ± 9 % rounded cells per total cells after 2 h compared to basal levels of 
about 12 %. In consideration of the standard deviations, TcdA and TcdB levels released from the C. difficile strains 
cdi630∆erm and cdi630∆tcdE were comparable, although the TcdE- knockout strain showed a slight increase in toxin 
release. Values are given as means ± standard deviations (n = 10). 
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Therefore, Hep2 cells were exposed to supernatants of C. difficile strains cdi630∆erm and 
cdi630∆tcdE cultivated for 48 h. Cytopathic effect (cell rounding), which is based on 
disassembly of the actin cytoskeleton, was quantified 0 h and 2 h after addition of toxins as 
rounded cells per total cells (%). Cell morphology of Hep2 cells treated with supernatant of 
the reference strain cdi630∆erm is exemplified in Fig. 4.21 [A] displaying toxin- induced cell 
rounding. Quantification is shown in Fig. 4.21 [B].  
 
 
Basal levels of cell rounding subsequently upon exposure of the cells to the supernatants 
were about 12 %. Two hours after treatment, supernatants from reference strain 
cdi630∆erm and mutant strain cdi630∆tcdE caused cell rounding of 42 % ± 7 % respectively 
52 % ± 9 %. In consideration of the standard deviations, these data support the results of 
Western blot analysis. TcdE- knockout strain cdi630∆tcdE exhibited similar amounts of 
released TcdA and TcdB compared to the reference cdi630∆erm. However, the TcdE-mutant 
strain showed a slight increase in toxin release. 
Taken together, the data indicate no decisive involvement of TcdE in the release of the 
pathogenic toxins from C. difficile as it was suggested by Dove et al. (1990). 
 
 
 
4.4.4 Comparative analysis of growth rates and sporulation 
efficacies of C. difficile strain 630∆erm and the respective TcdE- 
knockout strain cdi630∆tcdE  
 
Growth and sporulation rates of C. difficile strain 630∆erm and TcdE- knockout strain 
cdi630∆tcdE were examined to investigate a possible correlation with TcdE expression. The 
results are illustrated in Fig. 4.22. The optical density (OD600, filled squares) reflecting 
bacterial growth was determined in a time dependent manner. After 24 h of cultivation 
growth curves of cdi630∆erm and cdi630∆tcdE exhibited an OD600 maximum of almost 1.8. 
Following cultivation, optical densities decreased within 48 h to a constant value of 0.5. 
Interestingly, this reduction in cell count was accompanied by an increase in the sporulation 
rate (filled circles). While no sporulation occurred until 24 h, 18 % ± 4.5 % of bacteria of 
strain 630∆erm (black circles) and 23 % ± 10 % of the strain cdi630∆tcdE (red circles) formed 
endospores after 48 h. After 72 h of cultivation, sporulation of both strains resulted in the 
same value of approximately 25 %. Thus, the TcdE- knockout strain cdi630∆tcdE possessed a 
marginal increased sporulation rate at 48 h compared to the respective reference strain 
cdi630∆erm. Even under standardized conditions these results showed high standard 
deviations. This phenomenon might contribute to sensitive bacterial growth which 
depended on conditions as temperature, pH value, cell count et cetera. 
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In consideration of even high standard deviations TcdE did neither affect kinetic of 
sporulation nor absolute sporulation values. The reduction in cell count and an increase of 
sporulation was the only correlation that was observed in this study independently of TcdE 
expression. 
 
 
 
Fig. 4.22: Comparative analysis of growth rates and sporulation efficacies of C. difficile strain 630∆erm and the respective 
TcdE- knockout strain cdi630∆tcdE. Growth profiles of cdi630∆erm and the mutant strain cdi630∆tcdE developed 
congruently with an OD600 maximum of 1.8 at 24 h followed by a strong decrease to a constant value of 0.5 after 48 h and 
72 h of cultivation. Interestingly, this rapid reduction in cell count was accompanied by an increase in sporulation to 
18 % ± 4.5 % for cdi630∆erm (red circles) and 23 % ± 10 % (black circles) for the respective TcdE- knockout strain 
cdi630∆tcdE. Values are given as means ± standard deviation (n=10).     
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5. Discussion 
 
5.1 Effect of Clostridium difficile TcdE on bacteria 
 
The small open reading frame tcdE within the pathogenicity locus of Clostridium difficile 
encodes a 19 kDa, highly hydrophobic protein of unknown function. Since C. difficile resides 
in the colon, TcdE could be involved in virulence by affecting either intestinal commensals or 
the enterocytes. Otherwise, TcdE could have regulatory function with regard to expression 
or release of the toxins A and B. Previous studies revealed a correlation between TcdE 
expression and inhibition of bacterial growth, however, without detection in SDS-PAGE or 
immunoblot. Amino acid sequence analysis supported the idea of TcdE as bacteriolytic 
protein because of sequence and structural homologies to bacteriophage-encoded holins 
(Tan et al., 2001). The present study investigates different aspects of TcdE function including 
structure-function analysis, effects on E. coli and epithelial cells and involvement in specific 
features of C. difficile like sporulation, growth and toxin release. The analyzed putative 
functions of C. difficile TcdE are illustrated in the scheme below. 
 
 
 
 
 
 
Fig. 5.1: Putative functions of C. difficile TcdE. 
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5.1.1 TcdE induces lysis of E. coli 
 
T7 Express lysY/Iq competent Escherichia coli were used to investigate TcdE-induced 
inhibition of bacterial growth as they afford a tight expression control enabling cloning of 
toxic genes. Growth profiles of E. coli transformed with wildtype TcdE showed a strong loss 
of culture turbidity already 30 min after induction. This phenomenon was not observed in 
E. coli transformed with the empty vector (Fig. 4.1 [A]). Since TcdE shares sequence and 
structure homologies to bacteriophage-encoded lytic holins, decrease in optical density was 
supposed to be based on TcdE-induced bacteriolysis. This assumption was supported by ATP 
release from E. coli as marker for cell lysis. Tan and co-workers also showed gradual loss of 
culture turbidity after induction of E. coli transformed with a TcdE-construct, which was 
independent on media, E. coli strains and temperature. The hypothesis that the site of action 
of TcdE is at bacterial cell membranes was supported by Transmission electron microscopy 
confirming loss of membrane integrity and bacterial death as a result of membrane 
disruption (Tan et al., 2001). However, the authors were unable to detect the protein TcdE 
by SDS-PAGE or immunoblot analysis and, thus, couldn’t verify the causal correlation for 
TcdE-induced bacteriolysis.   
The unsuccessful attempts to visualize TcdE by SDS-PAGE indicated that protein quantities 
below the SDS-PAGE resolution are sufficient for affecting cell growth. Therefore we 
generated a specific polyclonal rabbit antibody for detecting TcdE in a more sensitive 
Western blot. In fact we confirmed the expression of the predicted 19 kDa protein in E. coli 
finally adducing evidence for TcdE-mediated lysis of bacteria. Interestingly, an additional 
16 kDa protein was detectable with a tenfold excess compared to the 19 kDa full length 
protein.  
Furthermore, growth profiles of E. coli expressing TcdE showed a transient reduction in 
optical density. Two hours after induction minimal cell count was reached followed by a 
recovery of bacterial population. Also Goh and co-workers observed a biphasic growth 
profile of E. coli expressing TcdE without performing any further investigations or giving 
explanations. As the reversal in growth inhibition correlated with disappearance of TcdE 
protein after 3 h (Fig. 4.9) and a second IPTG induction after 24 h didn’t induce inhibitory 
effects again (Seehase S.), DNA sequencing of single colonies was performed; the aim was to 
investigate molecular effects of TcdE expression on the bacterial genome. Sequence analyses 
excluded that this phenomenon was due to a loss of the plasmid harboring the tcdE-
construct. Rather, base insertions of 700 bp to 1,000 bp into the tcdE gene were observed 
causing its disruption (Seehase S.). Hence, mutational inactivation can be construed as a 
bacterial regulation against TcdE-induced toxicity leading to a mixed population of E. coli. It 
has still to be clarified whether growth recovery 3 h after induction of TcdE expression is also 
due to a functional inactivation of the gene. 
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5.1.2 Role of the dual start motif and impact of TcdE domains 
 
Many bacteriophage-encoded holins use a dual start motif to produce two proteins differing 
in length and function: the holin and its inhibitor the antiholin, which possess a Met-Lys 
extension in case of the λ-holin. Interestingly, analysis of the tcdE nucleic acid sequence 
revealed two additional ATG start codons contributing to amino acids 25 and 27. 
Additionally, an alternative Shine-Dalgarno sequence, which is part of the ribosome binding 
site, was found upstream of both the first (GGTGG) and third (GGAGG) start codons of tcdE 
(Dove et al., 1990) indicating the existence of a functional dual start motif. The TcdE protein 
expression pattern supported the hypothesis since a 16 kDa protein was detected in addition 
to the 19 kDa full length TcdE (Fig. 4.1 [B]). This was in accordance with the deduced 
molecular weights of the proteins initiating from the second/third putative translation 
initiation sites (Tan et al., 2001).  
To investigate the putative dual start motif, TcdE mutants exhibiting point mutations within 
the Shine-Dalgarno sequence or the alternative ATG start codons (Fig. 4.5) were generated 
and expressed in E. coli. The expression pattern of wildtype TcdE revealed only 10 % of 
19 kDa full length TcdE compared to about 90 % of truncated 16 kDa protein 
(Fig. 4.6 [A], 1st panel). As the antiserum recognizes the C-terminus of TcdE, truncation is very 
likely at the N-terminal part. Furthermore, protein detection correlated well with the 
respective growth profile of wildtype TcdE. Already 0.5 h after induction strong protein 
expression occurred correlating with a dramatic decrease in culture turbidity (Fig. 4.6 [A] and 
Fig. 4.7). Subsequently, protein levels remained constant up to 3 h post-induction followed 
by a consecutive disappearance of full length and truncated TcdE. Interestingly, protein 
abortion was associated with recovery of bacteria population. Unfortunately, the evidence 
of a mixed population of E. coli still expressing the lytic TcdE and those containing a 
disrupted or lost tcdE gene was observed for bacteria grown for 24 h. Thus, DNA insertion 
into the tcdE gene as bacterial counter-regulation against TcdE-induced toxicity might not 
explain the early reversal in growth inhibition.   
The Shine-Dalgarno mutants SD I and SD II, exhibiting two or rather three point mutations 
within the Shine-Dalgarno sequence (Fig. 4.5), showed different expression pattern 
compared to wildtype TcdE. The ratio of full length (19 kDa) to truncated TcdE (16 kDa) 
shifted from 1 : 10 to about 1 : 1.5 for SD II confirming a reduced translation initiation from 
the third start codon as a result of ribosome binding site mutations and thus, the existence 
of a functional dual start motif. Interestingly, the shift of the ratio of full length to truncated 
TcdE altered kinetic of the recovery of the bacteria population. Wildtype TcdE, expressing 
only 10 % full length and 90 % short TcdE, showed the fastest reversal in growth inhibition 
after 2 h whereas E. coli producing full length and short TcdE in a ratio of 40 % to 60 % (SD II) 
recovered with a two hours delay (Fig. 4.6 and Fig. 4.7). The reversal in bacterial growth can 
be interpreted as a successful response to the strong selection force of bacteriolytic TcdE. 
This conclusion is supported by the Methionine-mutant, which exclusively expresses full 
length TcdE and indeed induces plateau of bacterial growth but not lysis.  
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While recovery time depended on the ratio of full length to truncated TcdE, kinetic of lysis 
was not altered since the growth curves regarding wildtype TcdE and the SD mutants 
developed congruently up to 2 h (Fig. 4.7). Thus, the presence of truncated TcdE per se is 
more important that the ratio to the full length protein. 
It is known that the λ-holin S105 and the antiholin S107, which possesses a Lys-Met- 
extension, are produced during infection at a constant ratio of 2:1 (Bläsi and Young, 1996; 
Ryan and Rutenberg, 2007). It was suggested that the holin and antiholin molecules 
accumulate as a hetero-oligomeric patch at the inner membrane and rearrange in a second 
step to form a pore. This rearrangement is essential, but inhibited by the interaction of the 
amino-terminal positive charge (Lys) of the S107 molecules with the negatively charged 
inner surface of the energized membrane. As described in detail by Bläsi et al. (1990), S107 
acts as lysis inhibitor as long as the membrane potential is maintained and it also contributes 
actively to pore formation when the membrane potential collapses. Thus, not only the two 
protein products S105 and S107 have opposing function but also the so called antiholin itself 
has dual capacity.  
A similar process can be suggested for TcdE. Since TcdE mutant ∆N∆C, only consisting of the 
three transmembrane domains (TMDs), inhibited bacterial growth whereas a fusion 
construct of only the N- and C-termini didn’t appreciably affect growth of bacteria, the three 
TMDs are shown to be essential for TcdE-induced bacteriolysis (Fig. 4.4). Full length TcdE 
didn’t induce lysis as shown by growth profiles and absent ATP release. Thus, it can be 
postulated that the hydrophilic, weak positively charged N-terminus (Fig. 5.2, green bar) 
prevents the first TMD from inserting into the cytoplasmic membrane resulting in insertion 
of only two TMDs (Fig. 5.2 [A], right panel) which probably are not capable of inducing lysis.  
 
 
 
Fig. 5.2: Topological models for full length and truncated TcdE. [A] The 19 kDa full length TcdE possesses a hydrophilic, 
weakly positively charged N-terminus (green bar), three hydrophobic transmembrane domains (TMDs, grey bars) and a 
hydrophilic C-terminus (red bar). The N-terminus is supposed to retain the first TMD within the cytoplasm enabling 
insertion of only two TMDs into the cytoplasmic membrane (right panel). [B] The lack of the N-terminal region of TcdE 
allows the first TMD to insert into the membrane (right panel) leading to a potent lysis effector.  
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In contrast, truncated TcdE, consistent with the mutant TcdE∆N, lacks the N-terminal region 
and consequently enables the first transmembrane domain to insert into the membrane 
causing lysis of bacteria (Fig. 5.2 [B], right panel). This model is supported by the observation 
that the N-terminal deletion mutant TcdE∆N induced faster counterregulation of bacteria 
(Fig. 4.4 [A], blue curve) than wildtype TcdE expressing at least 5-10 % full length protein 
(Fig. 4.4 [A], red curve). The C-terminus probably has modulatory function and stabilizes the 
transmembrane domains within the cytoplasmic membrane. 
 
The λ-holin derived protein products S105 and S107 only differ in a two amino acid extension 
of the antiholin S107 whereas the putative lytic TcdE (16 kDa truncated form) lacks about 
25 amino acids compared to the putative inhibitor (19 kDa full length TcdE). Our data 
support the notion that lysis mechanism sensitively depended on N-terminal amino acid 
extensions of the truncated TcdE: an N-terminal located, weakly positively charged 6xHis-tag 
abolishes the bacteriolytic effect of TcdE∆N (not shown).  
 
Taken together, the tcdE gene of Clostridium difficile exhibits a dual start motif resulting in 
the synthesis of two polypeptides, a 19 kDa full length and a 16 kDa truncated TcdE, the 
latter lacking the N-terminus only consisting of the three transmembrane domains (TMDs) 
and the C-terminus. C. difficile TcdE causes bacteriolysis of E. coli which is mediated by its 
truncated product, the N-terminal deleted 16 kDa protein. Alterations of the usually 
observed 1 : 10 ratio of full length to truncated TcdE with respect to higher quantities of the 
19 kDa protein result in attenuation of the lytic properties indicating an inhibitory impact of 
the full length TcdE. It is suggested that lysis function requires oligomerization of TcdE 
monomers through their TMDs. The hydrophilic, weakly positively charged N-terminus of the 
full length TcdE presumably interacts with the inner surface of the cytoplasmic membranes 
preventing the first TMD from membrane insertion. In contrast, lack of the N-terminal region 
of the truncated TcdE enables all three TMDs to insert correctly into the cytoplasmic 
membranes and to form a lethal hole. A heterodimer of full length and truncated TcdE 
would be consequently less effective in lysis than a homodimer of N-terminal shortened 
TcdE. 
 
 
 
5.2 C. difficile TcdE does not induce apoptosis 
 
In addition to intestinal commensals, enterocytes are also in close vicinity to Clostridium 
difficile. Therefore, the enterocytes are possible targets for the holin-like TcdE, although 
eukaryotic cells differ fundamentally from prokaryotic cells in terms of their cellular 
structure, organization, metabolism and membrane composition (Tannert et al., 2003). 
Recently it was shown by cell viability assays that the bacteriophage λ-holin is cytotoxic to 
eukaryotic cells accounting for a reduced tumor growth in vivo (Agu et al., 2006). To 
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investigate the impact of C. difficile TcdE on eukaryotic cells, the capability of wildtype TcdE 
and/or the N-terminal deletion mutant TcdE∆N of releasing cytochrome c from isolated 
mitochondria was checked. Neither the mixture (ratio 1 : 10) of full length and truncated 
TcdE nor truncated TcdE alone caused mitochondria disruption. A putative impact of TcdE on 
the intact cell was studied by transfection of cells with the TcdE constructs to analyze cell 
and nuclei morphology and to detect putative activation of an apoptotic signal cascade.  
Full length TcdE as well as the N-terminal shortened bacteriolytically active product was 
localized to the cytoplasm with a strong enrichment around the nucleus. Interestingly, TcdE 
didn’t locate to cytoplasmic membranes as it was shown for prokaryotes. Similar 
observations were made with bacteriophage-encoded λ-holin. The presence of λ-holin 
protein in nuclei and cytoplasmic membranes was excluded. Instead, colocalization 
experiments confirmed localization of the holin in endomembranes, more precisely in the 
membranes of the endoplasmic reticulum (ER) and the mitochondria. This might be due to 
the bacterial ancestry of eukaryotic endomembranes (Agu et al., 2007). The observed 
expression pattern of TcdE might also indicate localization of the hydrophobic TcdE within 
the eukaryotic endomembranes. The observed “maze-like” structures might represent the 
ER membranes within the cytoplasm with higher density around the nucleus. Additionally, 
the described bright “spots” can either be a result of accumulated protein due to high 
concentrations or might indicate localization of TcdE within the mitochondrial membranes. 
However, localization of a pore-forming protein within the ER membrane would have 
affected ER calcium homeostasis leading to cell death, as shown for aerolysin secreted by 
Aeromonas hydrophila (Krause et al., 1998). The same would result upon pore-formation in 
the mitochondria membrane since membrane depolarization as consequence of non-
selective diffusion of molecules across the mitochondrial inner membrane in turn leads to 
rapid ATP depletion and cell death (Kim et al., 2003). Dependent on the mode of action 
apoptosis or oncosis occurs (Cherla et al., 2003; Chakrabarti and McClane, 2005; Nottrott et 
al., 2007). Apoptosis typically involves cellular shrinkage, nuclear condensation and 
fragmentation and the activation of caspases. However, neither expression of full length 
TcdE nor of the bacteriolytic short product altered morphology of nuclei up to 48 h after 
transfection or cell morphology, as shown on the basis of actin cytoskeleton staining. In 
addition, counterstain of the activated caspase-3 was performed but didn’t provide an 
indication of TcdE inducing apoptosis. In reverse conclusion, a virulent impact of TcdE is 
most unlike. 
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5.3 TcdE in context of Clostridium difficile characteristics 
 
5.3.1 Release of the toxins A and B 
 
The previous results definitely excluded the notion of Clostridium difficile TcdE acting as 
pathogenicity factor. Instead, TcdE was investigated to obtain regulatory function with 
regard to release of the pathogenic toxins A and B. As shown, TcdE possesses a holin-like 
mode of action in bacteria as it induced lysis of E. coli. Since the toxins A and B lack signal 
peptides for extracellular secretion and no export mechanisms for the toxins are identified, 
TcdE was supposed to facilitate the release of the pathogenic glucosyltransferases from 
C. difficile to the extracellular environment (Tan et al., 2001). This hypothesis was supported 
by the observation that tcdE was polycistronically transcribed together with the tcdA-D 
genes during the stationary phase of growth (Hundsberger et al., 1997). Analysis of toxin 
production of the reference strain C. difficile VPI10463 confirmed an association between 
appearance of TcdE in the membrane fraction and accumulation of TcdA and TcdB in the 
respective supernatants (Fig. 4.12). To investigate a potential causal correlation between 
TcdE expression and toxin A/B release a TcdE deficient mutant was generated by insertional 
inactivation of the tcdE gene within C. difficile strain 630∆erm (Chapters 4.4.1 and 4.4.2). 
This method is based on specific insertion of a modified group II intron into the target gene 
causing gene disruption and subsequent prevention of protein expression, as confirmed by 
Western blot analysis (Fig. 4.19). Comparative analysis of the C. difficile strain cdi630∆erm 
and the respective TcdE- knockout strain cdi630∆tcdE revealed almost equal toxin levels 
released into the supernatant. The data were confirmed by treatment of epithelial cells with 
the respective supernatants and a subsequent monitoring of the cytopathic effect (Fig. 4.21). 
Cytotoxicity induced by the toxins of the supernatants was comparable for both strains 
reflecting comparable toxin quantities. Hence, the release of the toxins is independent of 
TcdE. This outcome is corroborated by the observation that exclusively the full length TcdE 
(19 kDa) is produced in C. difficile whereas bacteriolysis in E. coli was induced by the 16 kDa, 
N-terminal shortened protein.  
Moreover, the hypothesis that TcdE forms a lytic pore in C. difficile was questionable since 
the cytoplasmic membrane of Gram positive bacteria is covered by a thick, multilayered 
peptidoglycan requiring enzymes possessing murein hydrolase activity for its degradation. 
Although muralytic enzymes are known to be involved in completion of cell division of Gram 
positive bacteria (e.g. autolysin from Staphylococcus aureus) (Baba and Schneewind, 1998) 
and C. difficile phage φC2 was shown to exhibit a lysis module with holin and endolysin (Goh 
et al., 2007), there was no indication of bacteriolysis of C. difficile. Additionally, analysis of 
the extracellular fraction of C. difficile VPI10463 revealed marginal amounts of cytoplasmic 
proteins reflecting a small fraction of lysed cells further arguing against bacterial lysis as 
route for release of the toxins A and B (Mukherjee et al., 2002)   
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For these reasons C. difficile TcdE is excluded to participate in, much less, to be responsible 
for the release of the pathogenic toxins into the extracellular environment.  
 
 
5.3.2 C. difficile growth and sporulation   
 
The 16 kDa, N-terminal shortened TcdE was shown to be crucial for bacteriolysis in E. coli 
whereas the 19 kDa product had inhibitory effect concerning holin action and bacterial 
growth. Since C. difficile exclusively expresses the 19 kDa, full length protein (Fig. 4.12 (A) 
and Fig. 4.19) we addressed the question whether TcdE might also arrest growth of 
C. difficile and conceivably cause a shift to toxin synthesis. However, as shown in the former 
chapter TcdE did not affect the toxin levels released from C. difficile. Additionally, 
comparative analysis of time-dependent cell count of the C. difficile strain cdi630∆erm and 
the TcdE deficient strain cdi630∆tcdE demonstrated that TcdE is not involved in regulation of 
C. difficile growth as the resulting growth curves developed congruently (Fig. 4.22, filled 
squares). 
The reference strain C. difficile VPI10463 and the hypervirulent strain 196 revealed 
conspicuous differences in sporulation efficacies (Fig. 4.15) as also observed with another 
PCR ribotype 027 strain by Akerlund and colleagues (Akerlund et al., 2008). Comparative 
analysis of TcdE expression of cdiVPI10463 and cdi196 was performed to examine a potential 
impact of TcdE in sporogenesis. TcdE production of both strains acted on the same kinetic 
but, interestingly, the high sporulating strain C. difficile 196 reflected an expression level 
which was 5-fold less than that of the low sporulating, high toxin producing strain VPI10463. 
Comparison of sporulation rates of cdi630∆erm and the TcdE-knockout strain cdi630∆tcdE, 
however, didn’t verify a correlation (Fig. 4.22, filled circles). Indeed, cdi630∆tcdE tended to 
exhibit a marginal higher sporulation rate after 48 h cultivation. But nevertheless, 
involvement of TcdE in sporogenesis can be excluded.  
Apart from that, toxin release was accompanied by a reduction in cell count (Fig. 4.13) 
indicating a lysis- or sporulation- based release of TcdA and TcdB. Interestingly, the 
sporulation rate of the reference strain VPI10463 was only 5 % clearly arguing against a 
sporulation-mediated toxin release. Ketley and co-workers didn’t show any correlation 
between TcdA release and sporogenesis in C. difficile strain 8089 either (Ketley et al., 1986). 
This result was confirmed by Mukherjee and colleagues since they found small amounts of 
typical cytoplasmic proteins in the culture supernatant of C. difficile strain VPI10463 
probably reflecting small quantities of lysed respectively sporulated cells that cannot explain 
the efficient toxin release of 50 % (Mukherjee et al., 2002). In contrast, other previous 
studies showed a correlation of sporogenesis and toxin release (Boriello and Barclay, 1986; 
Kamiya et al., 1992) confirming the results obtained in this study concerning C. difficile strain 
630∆erm and the hypervirulent strain 196 showing that sporulation was accompanied by an 
increase of toxin levels in the supernatant.   
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Finally, data of this study evidenced that C. difficile TcdE is neither decisively involved in the 
release of the toxins into the extracellular environment nor in the regulation of bacterial 
growth and sporogenesis. The controversial results regarding the correlation of toxin release 
and sporulation obtained from the literature and from this study eventually excluded 
sporogenesis-mediated lysis as the route for the release of the toxins. The investigated 
strains indeed differed in sporulation frequency but were together comparable to release 
rate of their toxins.   
 
 
5.4 Potential function of C. difficile TcdE 
 
The small hydrophobic TcdE from C. difficile was examined with regard to a potential virulent 
impact on epithelial cells as intestinal targets. However, recombinant TcdE neither affected 
nuclei and cell morphology nor induced apoptotic signal cascades reflecting a non-
pathogenic role in C. difficile associated disease. TcdE was furthermore excluded to 
participate in the release of the pathogenic toxins A and B or to influence C. difficile growth 
and be involved in sporogenesis.   
TcdE induced bacteriolysis in E. coli mediated by an N-terminal shortened TcdE which 
expression is regulated by a dual start motif, as it is known for bacteriophage-encoded 
holins. From this observation a potential role of TcdE in C. difficile colonization could be 
construed since TcdE is simultaneously expressed with TcdA and TcdB. Lysis of the intestinal 
Gram negative commensals by TcdE would facilitate and advantage C. difficile colonization. A 
role as colonization factor has to be investigated in more detail in further studies. 
Interestingly, previous studies identified homologies of tcdE, tcdA and tcdC to phage 
sequences of other species indicating that the pathogenicity locus of C. difficile was carried 
as part of a prophage that integrated at a specific site and conferred toxigenicity to ancestral 
C. difficile strains (Goh et al., 2005a; Goh et al., 2005b). TcdE was shown to be present in 
three temperate phages isolated from C. difficile (Goh et al., 2005b) further arguing for a 
holin-like mode of action of TcdE. However, the lytic impact was not observed in C. difficile. 
This matches with previous studies that examined the composition of extracellular proteins 
of C. difficile and excluded bacterial lysis as the route of toxin release (Mukherjee et al., 
2002).  
Since no contribution to growth regulation, sporogenesis and toxin release was observed for 
TcdE, the question arises about other tasks or whether TcdE has indirect functions. A 
hypothetical role might be to function as control element to prevent utilization of the 
pathogenicity locus through other bacterial species. In the case of phage infection, other 
bacteria species could gain access of the C. difficile PaLoc for instance through phage 
carriage or conjugation. The subsequent transcription under control of the alternative 
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ribosome binding sequence (Shine Dalgarno sequence) of tcdE would lead to an excess of 
truncated TcdE resulting - in cooperation with phage encoded endolysins - in lysis of the 
respective bacterium. Hence, tcdE could function like a Trojan Horse to defend the 
pathogenicity locus that is crucial for virulence of C. difficile. 
Alternatively, in contrast to the hypothesized bacteriolytic impact, TcdE might defend 
C. difficile from phage-mediated lysis after infection. C. difficile phages are shown to exhibit a 
lysis module consisting of holin and endolysin genes, whose expression presumably would 
result in cell death of clostridia (Goh et al., 2007). Since C. difficile exclusively produces full 
length TcdE, which acts as antiholin, TcdE could have antagonistic function towards the 
phage-holin and could cause deceleration or even inhibition of phage-induced lysis. Thus, 
this hypothesis would assign an indirect role in C. difficile colonization to TcdE as it 
potentially prolongs C. difficile survival after phage infection. 
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7. List of Abbreviations 
 
 
 
 
AEBSF    4-(2-Aminoethyl) benzenesulfonyl fluoride hydrochloride 
ATP    adenosine 5‘-triphosphate 
BSA    bovine serum albumin 
CDAD    Clostridium diﬃcile-associated diarrhea 
DAPI    4’,6’-diamidino-2-phenylindole hydrochloride 
DNA    desoxy ribonucleic acid 
dNTPs    deoxynucleotide-triphosphates 
DTT    dithiothreitol 
EDTA    ethylene diamine tetraacetic acid 
ELISA    enzyme-linked immunosorbent assay 
FBS    fetal bovine serum 
HCL    hydrochloride acid 
Hepes    4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
IPTG    isopropyl-D-thiogalatopyranosid 
LB    Luria Bertani 
MEM    Minimum Essential Medium 
MgCl2    magnesium chloride 
OD600    optical density at 600 nm 
PAGE    polyacrylamid electrophoresis 
PBS    phosphate buffered saline 
PCR    polymerase chain reaction 
SDS    sodium dodecyl sulfate 
SOE-PCR   Splicing by overlap extension PCR 
S105    holin protein of lambda phage 
S107    antiholin protein of lambda phage 
TBST    Tris buﬀered saline Tween-20 
TcdA    Clostridium diﬃcile toxin A 
TcdB    Clostridium diﬃcile toxin B 
TcdC    Clostridium diﬃcile toxin C 
TcdD    Clostridium diﬃcile toxin D 
TcdE    Clostridium diﬃcile toxin E 
TMD    transmembrane domain 
TNF-α    tumor necrosis factor α  
Tris    tris(hydroxymethyl)-aminomethan 
U    unit 
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A. Supplements 
 
A.1 Nucleotide sequences of generated pQE30 constructs 
The multiple cloning site of vector pQE30 contains the following inserted TcdE fragments. 
The ATG start codons are highlighted in green and the recognition sites of the respective 
endonucleases in blue: BamHI (5’ end) and Hind III (3’ end). Bases encoding the 6xHistidine 
tag are underlined. This region is deleted in constructs pQE30-TcdE∆N and pQE30-
TcdE∆N∆C. The alternative Shine-Dalgarno sequence is underlined in red and mutations are 
highlighted in red.    
 
Full length TcdE (C. difficile strain VPI10463) 
ATGAGAGGATCGCATCACCATCACCATCACGGATCCATGCACAGTAGTTCACCTTTTTA
TATTTCTAATGGTAACAAAATATTTTTTTATATAAACCTAGGAGGCGTTATGAATATGA
CAATATCTTTTTTATCAGAGCATATATTTATAAAGTTAGTAATTTTAACTATATCATTT
GATACATTATTAGGATGTTTAAGTGCAATAAAAAGTCGTAAATTTAATTCTAGTTTTGG
AATAGATGGAGGAATCAGAAAAGTAGCAATGATAGCATGTATATTTTTTTTATCAGTAG
TTGACATTCTTACAAAGTTTAACTTTTTATTTATGTTACCACAAGATTGTATCAATTTT
TTAAGACTAAAACATCTTGGAATATCTGAATTTTTCTCTATTTTATTTATTTTATATGA
AAGTGTAAGTATATTAAAAAATATGTGCTTATGTGGATTACCAGTACCTAAGAGATTAA
AGGAAAAAATAGCAATTTTACTAGATGCAATGACAGATGAAATGAATGCTAAGGGTGAA
AAGAAGCTT 
 
TcdE-NC (N-terminus: C. difficile strain 8864; C-terminus: C. difficile strain VPI10463) 
ATGAGAGGATCGCATCACCATCACCATCACGGATCAATGCACAGTAGTTCACCTTTATA
TTTTAATGGTAACAAAATATTTTTTTATATAAACCTAGGGGGCGTTATGAATATGGGTG
GTGGTGGTGGATCTAATATGTGCTTATGTGGATTACCAGTACCTAAGAGATTAAAGGAA
AAAATAGTAGTTTTACTAGATGCAATGACAGATGAAATGAATGCTAAGGGTGAAAAGGG
ATCCGGTGGTAAGCTT 
 
TcdE∆N (C. difficile strain VPI10463) 
ATGACAATATCTTTTTTATCAGAGCATATATTTATAAAGTTAGTAATTTTAACTATATC
ATTTGATACATTATTAGGATGTTTAAGTGCAATAAAAAGTCGTAAATTTAATTCTAGTT
TTGGAATAGATGGAGGAATCAGAAAAGTAGCAATGATAGCATGTATATTTTTTTTATCA
GTAGTTGACATTCTTACAAAGTTTAACTTTTTATTTATGTTACCACAAGATTGTATCAA
TTTTTTAAGACTAAAACATCTTGGAATATCTGAATTTTTCTCTATTTTATTTATTTTAT
ATGAAAGTGTAAGTATATTAAAAAATATGTGCTTATGTGGATTACCAGTACCTAAGAGA
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TTAAAGGAAAAAATAGCAATTTTACTAGATGCAATGACAGATGAAATGAATGCTAAGGG
TGAAAAGAAGCTT 
 
TcdE∆N∆C (C. difficile strain VPI10463) 
ATGACAATATCTTTTTTATCAGAGCATATATTTATAAAGTTAGTAATTTTAACTATATC
ATTTGATACATTATTGGGATGTTTAAGTGCAATAAAAAGTCGTAAATTTAATTCTAGTT
TTGGAATAGATGGAGGAATCAGAAAAGTAGCAATGATAGCATGTATATTTTTTTTATCA
GTAGTTGACATTCTTACAAAGTTTAACTTTTTATTTATGTTACCACAAGATTGTATCAA
TTTTTTAAGACTAAAACATCTTGGAATATCTGAATTTTTCTCTATTTTATTTATTTTAT
ATGAAAGTGTAAGTATATTAAAAAATATGTAGAAGCTT 
 
TcdE Shine-Dalgarno mutant I (TcdE SDI) 
ATGAGAGGATCGCATCACCATCACCATCACGGATCCATGCACAGTAGTTCACCTTTTTA
TATTTCTAATGGTAACAAAATATTTTTTTATATAAACCTATTAGGCGTTATGAATATGA
CAATATCTTTTTTATCAGAGCATATATTTATAAAGTTAGTAATTTTAACTATATCATTT
GATACATTATTAGGATGTTTAAGTGCAATAAAAAGTCGTAAATTTAATTCTAGTTTTGG
AATAGATGGAGGAATCAGAAAAGTAGCAATGATAGCATGTATATTTTTTTTATCAGTAG
TTGACATTCTTACAAAGTTTAACTTTTTATTTATGTTACCACAAGATTGTATCAATTTT
TTAAGACTAAAACATCTTGGAATATCTGAATTTTTCTCTATTTTATTTATTTTATATGA
AAGTGTAAGTATATTAAAAAATATGTGCTTATGTGGATTACCAGTACCTAAGAGATTAA
AGGAAAAAATAGCAATTTTACTAGATGCAATGACAGATGAAATGAATGCTAAGGGTGAA
AAGAAGCTT 
 
TcdE Shine-Dalgarno mutant II (TcdE SD II) 
ATGAGAGGATCGCATCACCATCACCATCACGGATCCATGCACAGTAGTTCACCTTTTTA
TATTTCTAATGGTAACAAAATATTTTTTTATATAAACCTATTAGTCGTTATGAATATGA
CAATATCTTTTTTATCAGAGCATATATTTATAAAGTTAGTAATTTTAACTATATCATTT
GATACATTATTAGGATGTTTAAGTGCAATAAAAAGTCGTAAATTTAATTCTAGTTTTGG
AATAGATGGAGGAATCAGAAAAGTAGCAATGATAGCATGTATATTTTTTTTATCAGTAG
TTGACATTCTTACAAAGTTTAACTTTTTATTTATGTTACCACAAGATTGTATCAATTTT
TTAAGACTAAAACATCTTGGAATATCTGAATTTTTCTCTATTTTATTTATTTTATATGA
AAGTGTAAGTATATTAAAAAATATGTGCTTATGTGGATTACCAGTACCTAAGAGATTAA
AGGAAAAAATAGCAATTTTACTAGATGCAATGACAGATGAAATGAATGCTAAGGGTGAA
AAGAAGCTT  
 
TcdE Methionine mutant II (TcdE Met) 
ATGAGAGGATCGCATCACCATCACCATCACGGATCCATGCACAGTAGTTCACCTTTTTA
TATTTCTAATGGTAACAAAATATTTTTTTATATAAACCTAGGAGGCGTTGCGAATTGCA
CAATATCTTTTTTATCAGAGCATATATTTATAAAGTTAGTAATTTTAACTATATCATTT
GATACATTATTAGGATGTTTAAGTGCAATAAAAAGTCGTAAATTTAATTCTAGTTTTGG
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AATAGATGGAGGAATCAGAAAAGTAGCAATGATAGCATGTATATTTTTTTTATCAGTAG
TTGACATTCTTACAAAGTTTAACTTTTTATTTATGTTACCACAAGATTGTATCAATTTT
TTAAGACTAAAACATCTTGGAATATCTGAATTTTTCTCTATTTTATTTATTTTATATGA
AAGTGTAAGTATATTAAAAAATATGTGCTTATGTGGATTACCAGTACCTAAGAGATTAA
AGGAAAAAATAGCAATTTTACTAGATGCAATGACAGATGAAATGAATGCTAAGGGTGAA
AAGAAGCTT 
 
A.2 Nucleotide sequences of generated pcDNA3.1 constructs 
The multiple cloning site of vector pcDNA3.1(-)A contains the following inserted TcdE 
fragments. The ATG start codons are highlighted in green and the recognition sites of the 
respective endonucleases in blue: XhoI (5’ end) and BamHI (3’ end). Bases encoding the 
6xHistidine tag are underlined. The myc epitope is highlighted by a dashed line.  
 
Full length TcdE (C. difficile strain VPI10463) 
CTCGAGCGATGCACAGTAGTTCACCTTTTTATATTTCTAATGGTAACAAAATATTTTTT
TATATAAACCTAGGAGGCGTTATGAATATGACAATATCTTTTTTATCAGAGCATATATT
TATAAAGTTAGTAATTTTAACTATATCATTTGATACATTATTAGGATGTTTAAGTGCAA
TAAAAAGTCGTAAATTTAATTCTAGTTTTGGAATAGATGGAGGAATCAGAAAAGTAGCA
ATGATAGCATGTATATTTTTTTTATCAGTAGTTGACATTCTTACAAAGTTTAACTTTTT
ATTTATGTTACCACAAGATTGTATCAATTTTTTAAGACTAAAACATCTTGGAATATCTG
AATTTTTCTCTATTTTATTTATTTTATATGAAAGTGTAAGTATATTAAAAAATATGTGC
TTATGTGGATTACCAGTACCTAAGAGATTAAAGGAAAAAATAGCAATTTTACTAGATGC
AATGACAGATGAAATGAATGCTAAGGGTGAAAAGGGATCCGAGCTCGGTACCAAGCTTG
GGCCCGAACAAAAACTCATCTCAGAAGAGGATCTGAATAGCGCCGTCGACCATCATCAT
CATCATCATTGA 
 
TcdE∆N (C. difficile strain VPI10463) 
CTCGAGCGATGACAATATCTTTTTTATCAGAGCATATATTTATAAAGTTAGTAATTTTA
ACTATATCATTTGATACATTATTAGGATGTTTAAGTGCAATAAAAAGTCGTAAATTTAA
TTCTAGTTTTGGAATAGATGGAGGAATCAGAAAAGTAGCAATGATAGCATGTATATTTT
TTTTATCAGTAGTTGACATTCTTACAAAGTTTAACTTTTTATTTATGTTACCACAAGAT
TGTATCAATTTTTTAAGACTAAAACATCTTGGAATATCTGAATTTTTCTCTATTTTATT
TATTTTATATGAAAGTGTAAGTATATTAAAAAATATGTGCTTATGTGGATTACCAGTAC
CTAAGAGATTAAAGGAAAAAATAGCAATTTTACTAGATGCAATGACAGATGAAATGAAT
GCTAAGGGTGAAAAGGGATCCGAGCTCGGTACCAAGCTTGGGCCCGAACAAAAACTCAT
CTCAGAAGAGGATCTGAATAGCGCCGTCGACCATCATCATCATCATCATTGA 
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A.3 Expected Cdi630-tcdE-234a targeting region 
The recognition sites of the respective endonucleases are highlighted in blue: HindIII (5’ end) 
and BsrGI (3’ end). The sequences of primers used for SOE-PCR are underlined: IBS (green), 
EBS2 (red) and EBS1d (blue). 
AAAAAAGCTTATAATTATCCTTAAATATCCATGCTGTGCGCCCAGATAGGGTGTTAAGT
CAAGTAGTTTAAGGTACTACTCTGTAAGATAACACAGAAAACAGCCAACCTAACCGAAA
AGCGAAAGCTGATACGGGAACAGAGCACGGTTGGAAAGCGATGAGTTACCTAAAGACAA
TCGGGTACGACTGAGTCGCAATGTTAATCAGATATAAGGTATAAGTTGTGTTTACTGAA
CGCAAGTTTCTAATTTCGATTATATTTCGATAGAGGAAAGTGTCTGAAACCTCTAGTAC
AAAGAAAGGTAAGTTAATAGCATGGACTTATCTGTTATCACCACATTTGTACAATCTG 
 
A.4 Plasmid map of pMTL007C-E2 
SOE-PCR is used to alter the IBS, EBS2 and EBS1d sequences and the resulting fragment is 
cloned between the HindIII and BsrGI sites to re-target the plasmid. RAM-E2 reflects the 
Retrotransposition-activated selectable marker coding for an erythromycin resistance which 
is activated after successful integration of the modified intron into the right target site.  
 
pMTL007C-E2
8926 bp
catP
LtrA
traJ
lacZalpha
RAM-E2
Csp fdx promoter
thl promoter
repH
ColEI RNA II
T1/T2 terminator
3' exon
FRT
FRT
BsrGI (420)
HindIII (190)
Sal I (2225)
BglII (414)
BglII (3693)
MluI (803)
MluI (2130)
Sac I (200)
Sac I (3364)
 
 
Plasmid pMTL007C-E2 was kindly provided by N. Minton (Centre for Biomolecular Sciences, University of Nottingham). 
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